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ABSTRACT 
 
 
BOLARINWA FUNGBE EKEZUE. Coronary revascularization strategies and the effects 
of diabetes complications on poor health outcomes (Under direction of Dr. SARAH B. 
LADITKA, and Dr. JAMES N. LADITKA)  
 
 
 Objectives: This research assessed the effect of comorbid diabetes complications 
on short-term adverse outcomes: in-hospital mortality, postoperative stroke, postoperative 
renal failure and readmissions within 30 days of discharge after coronary artery bypass 
graft (CABG) or percutaneous coronary intervention (PCI) among patients age 45 and 
older who have diabetes. The analysis compared differences in outcomes for CABG and 
PCI and for off-pump and on-pump CABG.  The analysis also focused on assessing 
associations between structure and process factors and the study outcomes.  Specifically 
for readmissions, the effect of discharge disposition was evaluated, including discharge to 
home without home health care (HHC), to home with HHC, and to a transitional care 
facility.  Methods: In-hospital mortality, postoperative stroke, and postoperative renal 
failure were assessed using the 2007 Nationwide Inpatient Sample (NIS) database.  
Readmission was categorized into early (≤10 days) and late (11 to 30 days), and assessed 
using the 2007 State Inpatient Databases (SIDs) for Arizona, California, and Florida.  
Analyses included chi-square, t-test, propensity adjusted multivariate logistic regression, 
multilevel regression, and Cox proportional hazard regression.  Analyses using the NIS 
data accounted for the survey design and were weighted for national representation.  
Covariates included age, race/ethnicity, health insurance, median household income, 
gender, 30 comorbidities, illness acuity measure, procedure volume and hospital 
characteristics.   Results: In adjusted analyses, patients with comorbid diabetes 
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complications were more likely to have in-hospital mortality with both CABG (Odds 
Ratio, OR 1.60; 95% Confidence Interval, CI 1.22-2.10) and PCI (OR 1.59, CI 1.27-1.99) 
than those without diabetes complications.  Their odds of renal failure were higher with 
PCI than CABG (OR 4.27 vs. 2.25, p<0.05).  Further, they were more likely to have 
postoperative stroke with off-pump CABG (OR 1.69, CI 1.10-2.60).  For readmissions, 
the adjusted hazard of early (Hazard Ratio, HR 1.24, CI 1.08-1.42) and late (HR 1.27, CI 
1.11-1.39) readmissions for those with comorbid diabetes complications and early (HR 
4.16, CI 3.53-4.91) and late (HR 1.88, CI 1.69-2.10) readmissions for patients discharged 
to a transitional care facility were higher.  Discharge to home with HHC (HR 1.24, CI 
1.12-1.36) was associated only with late readmission.  Discussion: Regardless of the 
revascularization strategy, patients with comorbid diabetes complications may have 
higher risks of in-hospital death after coronary revascularization.  Effects of comorbid 
diabetes complications on poor outcomes should be considered when making clinical 
decisions about CABG and PCI for patients with diabetes.  Comprehensive discharge 
planning may be needed to identify potential vulnerabilities, such as a predisposition to 
poor diabetes management for patients with comorbid diabetes, to reduce their risk for 
readmission.  Further research should examine the association between termination of 
HHC services and late readmission for patients using HHC services after discharge. 
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CHAPTER 1: INTRODUCTION 
 
 
Statement of Problem 
 
In the past two decades, health care expenditures in the United States have more 
than tripled, exceeding $2.3 trillion in 2008, representing over 16% of the national gross 
domestic product in 2008 (Kaiser, 2011).  Cost associated with the treatment of chronic 
conditions is one of the key drivers of health care cost increases.  With the aging of the 
baby boomers in the United States, and increased life expectancy, the prevalence of age-
related diseases, which are often chronic in nature, has markedly increased (Kung, 
Hoyert, Xu, & Murphy, 2008; Thrall, 2005).  Heart disease and diabetes are among the 
top five causes of mortality and morbidity in the United States.  The estimated direct and 
indirect costs of coronary artery disease (CAD) were about $177 billion in 2010 (CDC, 
2010); costs of diabetes were about $174  billion in 2007 (ADA, 2011).  Among the 25% 
of Medicare beneficiaries with the highest health care costs, 72% have CAD or diabetes 
(CBO, 2005).  Diabetes is often a comorbid condition of CAD; diabetes is associated 
with greater severity of CAD and poorer prognosis (Flaherty & Davidson, 2005; Resnick, 
Shorr, Kuller, Franse, & Harris, 2001).  Specifically, diabetes is associated with coronary 
calcification, diffuse CAD, narrow arterial vessels, and abnormal electric cardiographic 
measurements (Oei, Vliegenthart, Hofman, Oudkerk, & Witteman, 2004; Vaccaro et al., 
2004; Zornitzki et al., 2007).   The established treatment for CAD is coronary 
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revascularization, primarily coronary artery bypass graft (CABG) and percutaneous 
coronary intervention (PCI) (Eagle et al., 2004; Smith et al., 2001).   Outcomes of these 
procedures for patients with diabetes are often worse than those without diabetes (Berry, 
Tardif, & Bourassa, 2007; Bravata et al., 2007).  
As CABG and PCI are not equally optimal for all patients, research has sought to identify 
patients who will be more likely to benefit from CABG or PCI.  Research suggests that 
PCI may be more appropriate for persons with diabetes if CAD is less severe and affects 
only one or two vessels (Patel, Dehmer, Hirshfeld, Smith, & Spertus, 2009b; Smith, 
2009).  For patients with diabetes who have severe CAD, characterized by stenosis of the 
left main artery or three or more diseased vessels, studies suggest that CABG may be a 
more appropriate option (Patel, et al., 2009b; Smith, 2009).  The off-pump rather than on-
pump procedure for those undergoing CABG has been suggested for patients with 
diabetes, as these patients are in a high-risk group (Puskas et al., 2005).  Patients with 
diabetes are in a high-risk group because of anatomical, physiologic and metabolic 
dysfunctions.  Among individuals with diabetes, the development of diabetes 
complications are also risk factors for poor outcomes after revascularization (Barsness, 
Holmes, & Gersh, 2005; Creager, Lüscher, Cosentino, & Beckman, 2003; Jiménez-
Quevedo et al., 2009; Nesto, 2004; Reeder, Holmes, Lennon, Larson, & Frye, 2002).   
 Understanding how the presence of comorbid diabetes complications influences 
the outcomes of coronary revascularization can help to further clarify the benefits of 
revascularization strategies among patients with diabetes.  However, subgroup analyses 
in many observational studies and trials including patients with diabetes lack information 
about the presence of diabetes complications; thus, the effectiveness of PCI and CABG in 
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patients with diabetes complications is inclusive (Berry, et al., 2007; Bravata, et al., 2007; 
Serruys et al., 2009; Shroyer et al., 2009).Findings from this study can help to identify 
factors that predispose patients with diabetes to adverse outcomes, and provide 
opportunities for clinicians to provide necessary interventions.  Understanding factors 
that contribute to poor outcomes can also help clinicians to select patients for the 
appropriate revascularization strategy.  Reducing readmissions is important in improving 
the quality of life for patients after discharge.  Patients with diabetes have consistently 
been suggested to have greater risk of readmissions (Hannan et al., 2003; Slamowicz, 
Erbas, Sundararajan, & Dharmage, 2008; Stewart et al., 2000; Sun et al., 2008).  
Identifying characteristics that predict readmission risk in patients with diabetes can help 
to inform patients and care providers on factors to target in reducing readmissions. 
Background 
 The two surgical treatments of choice for people with severe coronary artery 
disease are coronary artery bypass grafts (CABG) and percutaneous coronary 
intervention (PCI).  CABG was the only surgical treatment until Andreas Gruentzig 
introduced coronary angioplasty in 1977, as a non-surgical substitute for treating CAD 
(Smith, et al., 2001).  More recently, technological advancements such as use of the drug 
eluting stent (DES) in PCI have improved the safety and effectiveness of PCI, leading 
some researchers to suggest that the two techniques may be equally effective (Bravata, et 
al., 2007; Smith, et al., 2001).  CABG is a more invasive procedure than PCI requiring a 
sternotomy and temporary stoppage or reduced blood flow to the heart.  Artery or vein 
harvested from the legs or breast bone is used to bypass blocked artery and restore 
normal blood flow to the heart (AHA, 2011b).  The CABG procedure can be performed 
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with or without cardiopulmonary machine. It is an off-pump CABG when the 
cardiopulmonary machine is not used and the heart remains beating during the procedure 
(Shekar, 2006).  Percutaneous coronary intervention refers to various angiographic 
techniques used to relieve coronary narrowing.  The early techniques involved using 
balloon to expand the artery whereas recent advancements include the use of stents with 
or without additional pharmacological treatment (Smith, et al., 2001).  While the surgical 
revascularization of atherosclerotic heart disease is a modern day success story, the 
improvement of the procedure achieved over time was through focused dedication and 
continued research.  Coronary artery disease is characterized by a gradual buildup of 
plaques in coronary arteries, restricting blood flow to the heart (AHA, 2011a).  Patients 
with coronary artery diseases experience chest pain as the heart is deprived of vital 
oxygen and in some cases a heart attack when there is complete blockage of blood flow 
to the heart (AHA, 2011a; Eagle, et al., 2004).   Coronary revascularization provides a 
means of restoring blood flow to the heart either by bypassing a blocked artery or 
expanding a narrow artery (Eagle, et al., 2004; Smith, et al., 2001).  The benefits of 
coronary revascularization include relief of angina, survival and improvement in quality 
of life (Eagle, et al., 2004; Hunt, Hendrata, & Myles, 2000; Sjoland et al., 1997; Smith, et 
al., 2001).  However, the success of coronary revascularization procedure: CABG and 
PCI is also measured in terms of absence of procedural complications such as death, and 
morbidities that adversely affect the quality of life or increase the likelihood of death, 
such as myocardial infarction, stroke and renal failure.  Thus, a number of studies have 
examined ways to improve CABG and PCI techniques and also to identify factors that 
increase patient‘s risks for adverse outcomes (Curtis et al., 2009; Do et al., 2002; Fuchs et 
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al., 2002; Gupta, Gurm, Bhatt, Chew, & Ellis, 2005; Pell et al., 2001; Peterson, Coombs, 
DeLong, Haan, & Ferguson, 2004).  Some of these factors include the surgical process; 
such as preoperative evaluation, anesthesia technique, perioperative monitoring of 
hemodynamic and physiological functions, the hospital environment; such as surgeon 
skills, procedure volume, staffing adequacy and patient‘s characteristics.  Patient risk 
factors that are associated with poor outcomes include advanced age, female gender, 
severe CAD, diabetes, impaired renal function, congestive heart failure and multiple 
comorbidites (Brooks et al., 2000; Cantor et al., 2002; Eagle, et al., 2004; Smith, et al., 
2001).   Research has indicated worse short-term and long-term outcomes after coronary 
revascularization for patients with diabetes (Brooks, et al., 2000; Cruz-Gonzalez et al., 
2010; Sun, et al., 2008; Whang & Bigger, 2000).   Patients with diabetes are particularly 
at risk for adverse outcomes because the changes caused by diabetes are antecedents to 
adverse outcomes independent of coronary revascularization (Beckman, Creager, & 
Libby, 2002; Creager, et al., 2003).  These changes can manifest as microvascular and 
macrovascular complications of diabetes.   
Overview of the Nationwide Inpatient Sample (NIS) and the State Impatient Sample SID 
Databases 
 
 The Nationwide Inpatient Sample (NIS) and the State Inpatient Database (SID) 
are hospital discharge databases maintained as part of the Healthcare Cost and Utilization 
Project (HCUP) by the Agency for Healthcare Research and Quality (AHRQ) (HCUP, 
2007).  The NIS is nationally representative administrative data representing all inpatient 
stays from a stratified 20% sample of United States community hospitals (HCUP, 2010).  
The SID databases contain all inpatient discharges from participating states, (HCUP, 
2011).  Data obtained from participating states are checked for inconsistencies and 
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edited; variables are coded so that coding is consistent across states.  Many quality 
assurance procedures are performed on the NIS and SID data to ensure consistent internal 
and external validity (HCUP, 2009).  The NIS database sampling used five nested 
stratification variables based on the characteristics of hospitals from the participating 
states; discharge sample weights were calculated as the probability of sampling within 
each stratum (HCUP, 2006).  Both NIS and SID databases have similar core data 
elements; de-identified inpatient discharge-level data with information about 
demographics, admission information, length of stay, payer information, diagnoses and 
procedures.  In addition, the NIS has information on hospital-level data such as location, 
ownership, bed size, staffing ratio, hospital state, and teaching status.  The SID database 
has medical and demographic information for patients, information about patients' 
discharge status, and information to identify multiple hospitalizations.  A limitation of the 
SID databases used for this research is that hospital characteristics such as teaching status 
and location were not included. 
Objective of Research 
 
This research has three objectives.  The first objective is to examine the effect of 
diabetes complications using three measures of adverse outcomes: in-hospital mortality, 
postoperative stroke, and renal failure among individuals with diabetes having CABG or 
PCI.  A related study objective is to compare outcomes for patients with comorbid 
diabetes with CABG and PCI.  The second objective is to compare in-hospital mortality, 
postoperative stroke, and postoperative renal failure for patients with diabetes who 
underwent off-pump or on-pump CABG.  A related study objective is to determine 
patient and hospital characteristics associated with off-pump CABG outcomes, and to 
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examine contextual factors that may be associated with outcomes for patients with 
comorbid diabetes complications.  The third objective is to assess readmissions that 
occurred within 30-day of discharge in patients with diabetes who had coronary 
revascularization.  Related to the third objective, I evaluated early readmissions, defined 
as readmissions that occurred within 10 days after discharge, and late readmissions, 
defined as readmissions that occurred after 10 days of discharge.  For early and late 
readmissions, I examined the effect of comorbid complications and discharge disposition.  
Although the literature suggests that poorer revascularization outcomes are associated 
with metabolic changes resulting from suboptimal glycemic control, little research has 
focused on the response of individuals with diabetes complications to revascularization 
procedures.  By quantifying adverse outcomes of diabetes complications among patients 
having either CABG or PCI, this research helps to identify the revascularization strategy 
that may offer better outcomes among patients with CAD and diabetes complications.  
Few studies have examined readmissions among patients with diabetes having coronary 
revascularization.  No study has assessed the effect of comorbid diabetes complications 
on readmissions among patients with diabetes after coronary revascularization.  Findings 
from research will expand on our understanding of how comorbid diabetes complications 
at the time of an index coronary revascularization hospitalization affect the likelihood of 
readmission.  Results will also help to identify patient characteristics that should be 
considered when planning post-discharge care for individuals who have diabetes undergo 
CABG or PCI, and provide information about potentially modifiable patient 
characteristics, which clinicians may be able to address to enhance outcomes.  
 
 
 
CHAPTER 2: LITERATURE REVIEW 
 
 
Introduction 
  
 Diabetes is a major health problem in the United States.  It affects about 24 
million people, with great costs (ADA, 2010).  Coronary artery disease (CAD), a major 
vascular complication of diabetes, is prevalent in adults with diabetes.  (Hammoud, 
Tanguay, & Bourassa, 2000; Resnick, et al., 2001)  Diabetes elevates the risk for 
coronary artery disease, and accelerates its progression (Resnick, et al., 2001).   With a 
projected increase in diabetes prevalence, health care needs associated with the disease 
are also likely to grow, along with their costs (Mokdad et al., 2003).  Heart disease care 
costs represent the largest single category of health spending in the United States, 8.3% 
of total health expenditures during 1997-2002 (Olin, 2005).  Of the 1.5 million 
revascularization procedures performed annually to treat coronary artery disease, about 
25% are for people with diabetes; these individuals experience more unfavorable 
outcomes than people without diabetes (Flaherty & Davidson, 2005). Coronary artery 
disease (CAD), characterized by blockages in the coronary artery due to arthrosclerosis, 
accounts for a large proportion of spending for heart disease.  Among the 25% of 
Medicare beneficiaries with the highest health care costs, 72% have CAD or diabetes 
(CBO, 2005).  Thus, it is useful to identify individual characteristics associated with 
adverse outcomes among patients with CAD and diabetes having revascularization. 
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In addition, it is useful to understand treatment options and care processes that are 
associated with better outcomes for individuals with CAD and diabetes.  This information 
can help to reduce health care costs related to CAD and diabetes, reduce the burden of 
secondary illnesses, and improve quality of life for persons with CAD and diabetes. 
Coronary artery disease (CAD) is a leading cause of mortality in the U.S.  In 
2006, CAD caused 425,425 deaths, representing a sixth of all deaths (Heron et al., 2009).  
As a result of the gradual build-up of cholesterol and plaque in the coronary artery, the 
artery of patient with CAD may become narrow or blocked (AHA, 2011a; Lloyd-Jones et 
al., 2010).  Consequently, blood flow to the heart is restricted, or stopped if the artery is 
blocked.  Often CAD is not diagnosed until a person suffers a heart attack (NHLBI, 
2009b).  CAD is more common in older adults because the incidence of CAD increases 
with age.  About 8% of adults age 20 and over in the United States have CAD (Pleis, 
Lucas, & Ward, 2009),  with most incident CAD occurring  in persons 60 years and older 
(Lloyd-Jones, et al., 2010).  Across all age groups, CAD death rates were highest for 
Blacks and lowest for Asians (NHLBI, 2009a).  Among non-Hispanic Whites (hereafter 
Whites), the prevalence is higher among men (9.4%) than women (6.9%).  Among non-
Hispanic Blacks (hereafter Blacks) CAD rates are higher for women than men (8.8% 
versus 7.8%); this is also true among Mexican Americans (6.6% for women versus  5.3% 
for men) (Pleis, et al., 2009).  CAD occurs at earlier ages among men than among 
women; the lifetime risk of developing CAD for men at age 45 is 11% higher than the 
comparable risk for women (Lloyd-Jones, Larson, Beiser, & Levy, 1999).  In a follow-up 
study of adults aged 45 to 64, the incidence of CAD per 1000 person-years was 12.9% for 
White men, 10.6% for Black men, 5.1% for Black women and 4.0% for White women.  
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When CAD cases from revascularization procedures were excluded, CAD rates were 
higher for Black men than for White men (Jones et al., 2002).   
Diabetes is a major risk factor for CAD, accelerates CAD progression (Resnick, et 
al., 2001), and is an indicator of worse outcomes after medical procedures (Vaccaro, et 
al., 2004; Zornitzki, et al., 2007).  People with diabetes are more likely to have more 
coronary calcification than others (Oei, et al., 2004), which is a marker for heart attack 
and coronary death (Detrano et al., 2008).  Some studies suggest that people with CAD 
and diabetes are less likely to report chest pain, have more significant coronary stenosis, 
and more abnormal electric cardiographic measurements than those without diabetes 
(Cariou et al., 2000; Ledru et al., 2001).  These differences may be due to greater 
microvascular vessel damage (Sobel, 2001).  Although factors such as age, hypertension, 
gender, and hyperlipidemia are strong predictors of CHD severity, diabetes is also a 
major risk factor, especially among women (Natali et al., 2000).   
 Surgical treatment is usually preferred for patients with advanced CAD, marked 
by substantial blockage of the coronary artery and restricted blood flow to the heart.  The 
two surgical treatments of choice for people with severe coronary artery disease are 
coronary artery bypass grafts (CABG) and percutaneous coronary intervention (PCI).  
CABG was the only surgical treatment until Andreas Gruentzig introduced coronary 
angioplasty in 1977, as a non-surgical substitute for treating CAD (Smith, et al., 2001).  
More recently, technological advancements such as use of the drug eluting stent (DES) in 
PCI have improved the safety and effectiveness of PCI, leading some researchers to 
suggest that the two techniques may be equally effective (Bravata, et al., 2007; Smith, et 
al., 2001).  Although CABG was the established surgical treatment for many years, most 
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revascularization procedures performed in the U.S. annually are PCI procedures.  The 
discharge rate for CABG in 2002-2004 was 25.2% whereas that of PCI was 59.2% 
(Lloyd-Jones, et al., 2010).    
The outcomes of PCI and CABG are well described in the literature (Eagle, et al., 
2004; Lloyd-Jones, et al., 2010; Smith, et al., 2001).  These outcomes can be beneficial or 
unfavorable.  Unfavorable short-term outcomes include adverse events during 
hospitalization such as death, stroke, renal failure, and short-term hospital readmission.  
Studies have suggested that certain patient populations experience better outcomes with 
CABG, and others with PCI (Eagle, et al., 2004; Patel, et al., 2009b; Puskas, et al., 2005; 
Smith, et al., 2001).  However, there are subgroups for who the optimal revascularization 
technique is less clear.  For example, subgroup analyses in many trials including patients 
with diabetes lack information about the presence of diabetes complications; thus, the 
effectiveness of PCI and CABG in patients with diabetes complications is not well 
supported in the literature (Berry, et al., 2007). 
Three Areas of Dissertation Research Focus  
 
The next sections describe the literature review I conducted on the outcomes:  in-
hospital mortality, postoperative stroke, and postoperative renal failure, and readmissions 
following coronary revascularization in patients with diabetes; comparing CABG and 
PCI outcomes, on-pump and off-pump CABG outcomes. 
CABG and PCI Outcomes 
 
 Considerable research is focused on the long-term effects of revascularization 
with regards to diabetes, such as restenosis and repeat revascularization (Berry, et al., 
2007; Bravata, et al., 2007; Kip et al., 2002; Kurbaan, Bowker, Ilsley, Sigwart, & 
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Rickards, 2001).  Much less research is focused on short-term outcomes of 
revascularization in patients with diabetes.  Common short-term outcomes include 
procedural adverse events, such as in-hospital mortality, postoperative stroke, and renal 
failure requiring hemodialysis.  The rate of in-hospital mortality after CABG varies 
across studies, in part due to methodological differences (Bittner & Savitt, 2002; Ellis et 
al., 1988; O'Connor et al., 1991).  Common risk factors for in-hospital mortality among 
CABG and PCI patients include being older or female, having a history of peripheral 
vascular disease or heart surgery, or having renal dysfunction, postoperative stroke, or 
diabetes (Gruberg et al., 2001; Stamou et al., 2001).    The incidence of adverse 
neurological effects due to cerebral vascular accidents (CVA) ranges between 0.05% to 
0.38% for PCI (Brown & Topol, 1993; Fuchs, et al., 2002), and 0.40% to 0.80% for 
CABG (Breuer et al., 1983; McKhann et al., 1997).  The wide ranges for these rates may 
be attributable in part to differences in the definition of CVA, or differences in study 
designs or research samples.  The CVA definition may be restrictive, as in cerebral 
infarction detected by imaging techniques.  Alternatively, CVA may be defined broadly 
to include transient ischemic attacks and loss of neurological function (McKhann, Grega, 
Borowicz, Baumgartner, & Selnes, 2006; Smith et al., 2006).  Stroke and renal 
dysfunction are sequelae of microvascular and macrovascular complications of diabetes 
and are major complications of coronary revascularization, particularly for individuals 
with compromised physiologic and metabolic status associated with diabetes 
complications, such as vessel shrinkage and reduced creatinine clearance (Beckman, et 
al., 2002; Fuchs, et al., 2002; Rosolova et al., 2008; Schachner, Zimmer, Nagele, Laufer, 
& Bonatti, 2005; Vlassara, 1997).  Despite the link between diabetes complications and 
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poorer outcomes after CABG and PCI, this relationship has received little attention in 
prior research.  
CABG and PCI Outcomes among Patients with Diabetes 
 
Epidemiological evidence suggests that the physiologic and metabolic 
dysfunction associated with diabetes contributes to worse outcomes among individuals 
with diabetes and comorbid atherosclerotic disease (Nesto, 2004; Yan, Ramasamy, Naka, 
& Schmidt, 2003).  Chronic hyperglycemia, dyslipidemia, and vascular inflammation 
cause arterial dysfunction, severity of arterial stenosis, and more diffuse CAD (Nesto, 
2004; Yan, et al., 2003).  In addition, hyperglycemia causes glycosylation of protein, a 
precursor to diabetes microvascular complications (Vlassara, 1997).  Hyperglycemia is 
also associated with platelet abnormalities, evident in a higher number of pro-coagulating 
platelets, a risk factor for thrombolytic events (Creager, et al., 2003).  Diabetic 
nephropathy, reduced creatinine clearance, and proteinuria are indicators of long-term 
poor glycemic control, and are associated with adverse short and long-term outcomes 
after coronary revascularization (Reeder, et al., 2002).  In addition to metabolic 
dysfunction, studies have suggested coronary artery remodeling, where the vessel 
dimension compensates to changes in atherosclerotic plaque build-up (Barsness, et al., 
2005).  This compensation is less than optimal in individuals with diabetes (Jiménez-
Quevedo, et al., 2009; Vavuranakis et al., 1997).  Coronary arteries of individuals with 
diabetes lack the tendency to compensate for changes caused by arthrosclerosis, which is 
linked with vessel shrinkage, a major risk factor for restenosis and adverse cardiac events 
after PCI (Cantor, et al., 2002; Jiménez-Quevedo, et al., 2009; Mazeika, Prasad, Bui, & 
Seidelin, 2003).  Some studies have suggested the optimal control of blood glucose may 
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reduce both mortality and illness severity.  Several studies found a significant reduction 
in mortality due to strict perioperative glucose control among patients having CABG 
(Díaz et al., 1998; Furnary et al., 2003; Malmberg et al., 1996).  Anatomical, physiologic 
and metabolic dysfunctions that affect individuals with diabetes are antecedent to 
diabetes complications, and are risk factors for severe CAD and for adverse short-and 
long-term outcomes of CABG and PCI.   
On-pump and Off-pump CABG Outcomes 
 
 Although research has not quantified the proportion of adverse outcomes 
attributable to use of the cardiopulmonary machine, there is evidence that patients having 
the on-pump procedure may be more likely to have complications, including 
postoperative stroke, renal failure, and mortality (Chen-Scarabelli, 2002).  The in-hospital 
mortality rate after on-pump CABG in patients aged 45 and older is between 3.5% to 
4.3%, a risk that is influenced by comorbidities, and perioperative and postoperative 
morbidities (Holmes, Kozak, & Owings, 2007).  For example, the mortality risk was 
twenty times greater for CABG patients who had acute renal failure that required 
hemodialysis compared to those without acute renal failure (Conlon et al., 1999).  
Similarly, stroke following on-pump CABG surgery is a serious complication associated 
with mortality (McKhann et al., 2002; Stamou, et al., 2001).  Further, hemodynamic 
changes due to cardiopulmonary bypass make the kidney susceptible to embolic damage 
and renal failure (Baker, Andrew, & Knight, 2001).   
On-pump and Off-pump Outcomes and Diabetes 
 
 Diabetes is an independent risk factor for CAD.  It accelerates the progression of 
CAD, and coronary artery stenosis, often making patients with diabetes candidates for 
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coronary revascularization (Barsness, et al., 2005).  The interest in off-pump CABG has 
grown because of its potential to minimize the risks associated with the bypass process.  
The majority of CABG procedures are performed using the on-pump technique because 
there is still a debate on the superiority of off-pump over on-pump CABG, although some 
studies have suggested that patients with certain risk factors are likely to have better 
outcomes with off-pump CABG (Ascione et al., 2002; D'Ancona et al., 2003; Newman et 
al., 1996).  These risk factors include advanced age, comorbid diabetes, and left 
ventricular dysfunction (Puskas, et al., 2005).  Patients with diabetes are considered high-
risk because CAD in patients with diabetes is more diffuse, involves multiple vessels, and 
often results in more severely occluded vessels with more rupture prone plaques (Cariou, 
et al., 2000; Ledru, et al., 2001; Moreno et al., 2000).  In addition, metabolic and 
hematologic abnormalities, such as platelet aggregation and poor creatinine clearance, 
elevate the risks for complications and adverse events (Reeder, et al., 2002).   
 Considering these risk factors, patients with diabetes may benefit from the off-
pump CABG strategy compared to on-pump CABG (Puskas, et al., 2005).  However, 
results from a small number of studies that have examined the efficacy of off-pump 
CABG for individuals with diabetes are mixed and inconclusive (Magee et al., 2001; 
Srinivasan, Grayson, & Fabri, 2004).  In a prospective study using the Society of 
Thoracic Surgeons (STS) database, including 2,891 patients with diabetes who had 
CABG, the off-pump procedure was not associated with lower mortality among those 
with diabetes; patients without diabetes did have lower mortality with off-pump CABG 
than those with diabetes (Magee, et al., 2001).  Similarly, in a recent study examining 
outcomes of off-pump and on-pump CABG in patients with diabetes, there was no 
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reduction in mortality for those undergoing the off-pump procedure; however, those with 
the off-pump procedure had significantly shorter length of stay, fewer blood transfusions, 
and less postoperative stroke (Srinivasan, et al., 2004).  Srinivasan and colleagues 
suggested that the lack of a significant association between the CABG procedure used 
and mortality may have been due to inadequate statistical power.  They also suggested 
that unmeasured factors, such as staffing issues and hospital characteristics, may have 
contributed to the results.  In addition, effects of comorbid complications of diabetes such 
as uncontrolled diabetes, retinopathy and nephropathy were not assessed, although 
studies have suggested these complications as risk factors for morbidity and mortality 
after coronary revascularization (Jones et al., 2008; Ono et al., 2006).  Patients with 
diabetes complications are a high-risk group that may benefit from off-pump CABG 
(Abraham et al., 2001; Magee, et al., 2001).  
Coronary Revascularization and Readmissions 
 
 Outcomes of coronary revascularization have been widely studied due in part to 
the complexity of the procedures, the volume, costs, and the characteristics of patients 
who are often candidates for revascularization.  Revascularization outcomes are 
evaluated to identify risks, to minimize adverse events, and to improve quality of care.  
While considerable efforts have been devoted to outcomes such as mortality, morbidity, 
and the need for repeat revascularization, research on readmission is limited.  Most prior 
research on readmissions related to coronary revascularization has focused on patients 
having CABG.  Very few studies have examined readmissions following PCI, although 
the number of PCIs in the U.S. is growing (Smith, et al., 2006).   
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Readmission rates vary by time interval, with readmission risk increasing with 
time following the index hospitalization.  The rate of 30-days readmission after discharge 
for CABG was 16% and the rate for 60-days readmission was 18% (Cowper et al., 1997; 
Stewart, et al., 2000).  In contrast, the rate of readmission for PCI patients was 14.6% 
after 30 days of discharge, and 48% after one year (Curtis, et al., 2009; Halon, Rennert, 
Flugelman, Jaffe, & Lewis, 2002).   
 Although readmission rates vary due to the heterogeneity of patients and their 
measured and unmeasured risk profiles, studies have suggested some factors that are 
consistently associated with readmissions.  These factors include older age, multiple 
comorbidities, diabetes, illness severity, being female, being African American, and 
having surgical complications (Beggs, Birkemeyer, Nugent, Dacey, & O'Connor, 1996; 
Ferraris, Ferraris, Harmon, & Evans, 2001; Hannan, et al., 2003; Slamowicz, et al., 2008; 
Stewart, et al., 2000).  In a follow-up study of patients who had isolated primary CABG, 
the risk of readmissions was 22%  greater for those with diabetes and only 12% greater 
for others (Stewart, et al., 2000).  Further, among low-risk CABG patients, 28% of those 
with diabetes were readmitted, compared to 21% of others (Sun, et al., 2008).  The 
association of diabetes with readmissions has also been found for PCI patients (Curtis, et 
al., 2009), especially those with sub-optimal glycemic control (Corpus et al., 2004; Moss, 
Klein, & Klein, 1999).   
 Post-discharge care may also influence readmission.  Increasingly, patients are 
discharged to transitional care facilities to reduce inpatient care costs.  Facilities 
providing transitional care include special units within the hospital, post-acute skilled 
nursing facilities, intermediate care facility and rehabilitation facility (AGS, 2007; Naylor 
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& Keating, 2008; Naylor, 2006).  From 1990-1998 CABG discharge from a medical 
center to transitional care increased by 40%, discharges with home cares services 
increased by 32%, and discharge to home without home care decreased by 42% (Lazar et 
al., 2001).   While studies have suggested that readmission rates from transitional care are 
high (Bini et al., 2010; Nasraway, Button, Rand, Hudson-Jinks, & Gustafson, 2000), few 
studies have assessed whether discharge to these facilities is associated with readmissions 
among revascularization patients. 
Gaps in the Literature 
 
 The literature review highlights the need for more research to address why 
patients with diabetes are more likely to have adverse outcomes following coronary 
revascularization.   The few studies that reported differences in outcomes between 
patients with diabetes and those without diabetes after coronary revascularization often 
lack statistical power (Banning et al., 2010; Jacobs et al., 1998) or did not examine the 
effect of comorbid diabetes complications (Clough et al., 2002; Mathew et al., 2004).  
Characteristics of patients included in the sample in a number of studies limit the 
generalizability of results (Barsness et al., 1997; Niles et al., 2001).  For readmissions, 
assessment has been in the general population of patients with diabetes (Jiang, Andrews, 
Stryer, & Friedman, 2005; Molina-Corona & Zonana-Nacach, 2010) or broadly among 
CABG or PCI patients (Curtis, et al., 2009; Hannan, et al., 2003; Stewart, et al., 2000; 
Sun, et al., 2008).  No study has examined the association of comorbid diabetes 
complications on readmissions among patients with diabetes having coronary 
revascularization. 
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New Contributions of this Dissertation Research 
 
 This dissertation research focused on examining the effect of comorbid diabetes 
complications on poor outcomes in patients 45 years and older with diabetes having 
coronary revascularization.  The sample was restricted to patients age 45 and older 
because increasing age is associated with having CABG or PCI and the risks for adverse 
outcomes after revascularization (Brooks, et al., 2000; Magee, Coombs, Peterson, & 
Mack, 2003; Vavlukis, Georgievska-Ismail, Bosevski, & Borozanov, 2006).  This study‘s 
analyses examined three areas.  In Chapters 3 and 4, I focused on procedural outcomes: 
in-hospital mortality, postoperative stroke and postoperative renal failure.  In addition, 
Chapter 3, I compared the experience of patients with diabetes complications having 
CABG with having PCI. In Chapter 4, I compared the experience of patients with 
complications of diabetes and those without with off-pump and on-pump CABG.   In 
Chapter 5, I focused on the association of comorbid diabetes complications and discharge 
disposition with 30-day readmissions.   
 Understanding the experience of individuals with diabetes complications after 
revascularization will help to identify the revascularization strategy that may offer better 
outcomes for patients with CAD and diabetes complications.  Further, the results of these 
analyses will help to clarify the benefits of off-pump CABG in patients with diabetes, and 
to identify patient and contextual factors that are associated with adverse outcomes 
following CABG.  In identifying predictors of readmissions for individuals with diabetes, 
this study will assess patient‘s characteristics at the time of an index coronary 
revascularization hospitalization that are associated with the likelihood of readmission.  
Moreover, this study‘s findings will add to the understanding of important factors to 
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consider when planning post-discharge care for individuals who have diabetes and 
revascularization procedures, and may help reduce readmissions in this high-risk group.   
  
 
 
CHAPTER 3: ASSOCIATIONS BETWEEN DIABETES COMPLICATIONS  
AND ADVERSE HEALTH OUTCOMES AFTER CORONARY 
REVASCULARIZATION 
 
 
Introduction 
 
 Heart disease care costs represent the largest single category of health spending in 
the United States, 8.3% of total health expenditures during 1997-2002 (Olin, 2005).  
Coronary artery disease (CAD), characterized by blockages in the coronary artery due to 
arthrosclerosis, accounts for a large proportion of spending for heart disease.  Diabetes is 
often a comorbid condition with CAD, and increases the cost and health care burden of 
CAD (Lloyd-Jones, et al., 2010).  Among the 25% of Medicare beneficiaries with the 
highest health care costs, 72% have CAD or diabetes (CBO, 2005).  Older adults with 
CAD and diabetes are more likely to have worse outcomes after coronary 
revascularization (Berry, et al., 2007; Bravata, et al., 2007).  Thus, it is useful to 
understand treatment options and care processes that are associated with better outcomes 
for individuals with CAD and diabetes.  It is also useful to identify individual 
characteristics associated with adverse outcomes among patients with CAD and diabetes 
having revascularization.  This information can help to reduce health care costs related to 
CAD and diabetes, reduce the burden of secondary illnesses, and improve quality of life 
for persons with CAD and diabetes. 
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Overview of Coronary Artery Disease and Diabetes 
 
Coronary artery disease is also known as atherosclerotic heart disease because of 
the gradual build-up of cholesterol and plaque in the coronary artery, which causes the 
narrowing and blockage of arteries (Lloyd-Jones, et al., 2010).  As the artery narrows, 
blood flow to the heart is restricted, or stopped if the artery is blocked.  Often CAD is not 
diagnosed until a person suffers a heart attack (NHLBI, 2009b).  CAD is a leading cause 
of mortality in the U.S.  In 2006, CAD caused 425,425 deaths, representing a sixth of all 
deaths (Heron, et al., 2009).  Across all age groups, CAD death rates were highest for 
Blacks and lowest for Asians (NHLBI, 2009a).   
About 8% of adults age 20 and over in the United States have CAD (Pleis, et al., 
2009).  Among non-Hispanic Whites (hereafter Whites), the prevalence is higher among 
men (9.4%) than women (6.9%).  Among non-Hispanic Blacks (hereafter Blacks) CAD 
rates are higher for women than men (8.8% versus 7.8%); this is also true among 
Mexican Americans (6.6% for women versus  5.3% for men) (Pleis, et al., 2009).  CAD 
occurs at earlier ages among men than among women; the lifetime risk of developing 
CAD for men at age 45 is 11% higher than the comparable risk for women (Lloyd-Jones, 
et al., 1999).  In a follow-up study of adults aged 45 to 64, the incidence of CAD per 
1000 person-years was 12.9% for White men, 10.6% for Black men, 5.1% for Black 
women and 4.0% for White women.  When CAD cases from revascularization 
procedures were excluded, CAD rates were higher for Black men than for White men 
(Jones, et al., 2002).   
Although CAD mortality rates have been trending downward since 1968, the 
largest percentage decrease in the general U.S. population and for Whites occurred from 
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1999-2006.  The decline was smaller for Blacks than for Whites (Heron, et al., 2009; 
NHLBI, 2009a).  Using data from 1980-2000 representing adults ages 25 to 84, 
researchers quantified the decline in CAD rates that were attributable to medical and 
surgical treatments compared to CAD risk factors modifiable by changes in health 
behaviors (Ford et al., 2007).  Ford et al. found that medical and surgical treatments 
accounted for 47% of the decrease, while changes in CAD risk factors accounted for 44% 
(Ford, et al., 2007).  However, increases in the prevalence of obesity and diabetes in the 
U.S. (Mokdad, et al., 2003; Mokdad et al., 2000) offset some of the gains from 
improvements in risk factors such as reducing cholesterol, blood pressure, and smoking 
(Ford, et al., 2007).  
Diabetes is a major risk factor for CAD, accelerates CAD progression (Resnick, et 
al., 2001), and is an indicator of worse outcomes after medical procedures (Vaccaro, et 
al., 2004; Zornitzki, et al., 2007).  People with diabetes are more likely to have more 
coronary calcification than others (Oei, et al., 2004), which is a marker for heart attack 
and coronary death (Detrano, et al., 2008).  Some studies suggest that people with CAD 
and diabetes are less likely to report chest pain, have more significant coronary stenosis, 
and more abnormal electric cardiographic measurements than those without diabetes 
(Cariou, et al., 2000; Ledru, et al., 2001).  These differences may be due to greater 
microvascular vessel damage (Sobel, 2001).  Although factors such as age, hypertension, 
gender, and hyperlipidemia are strong predictors of CHD severity, diabetes is also a 
major risk factor, especially among women (Natali, et al., 2000).   
Coronary Revascularization  
 
 The two surgical treatments of choice for people with severe coronary artery 
24 
 
 
        
disease are coronary artery bypass grafts (CABG) and percutaneous coronary 
intervention (PCI).  CABG was the only surgical treatment until Andreas Gruentzig 
introduced coronary angioplasty in 1977, as a non-surgical substitute for treating CAD 
(Smith, et al., 2001).  More recently, technological advancements such as use of the drug 
eluting stent (DES) in PCI have improved the safety and effectiveness of PCI, leading 
some researchers to suggest that the two techniques may be equally effective (Bravata, et 
al., 2007; Smith, et al., 2001).  Studies have suggested that certain patient populations 
experience better outcomes with CABG, and others with PCI (Eagle, et al., 2004; Smith, 
et al., 2001).  However, there are subgroups for whom the optimal revascularization 
technique is less clear.  For example, subgroup analyses in many trials including patients 
with diabetes lack information about the presence of diabetes complications; thus, the 
effectiveness of PCI and CABG in patients with diabetes complications is not well 
supported in the literature (Berry, et al., 2007). 
 A panel including cardiac surgeons, interventional cardiologists, and specialists 
rated common clinical scenarios for which patients would be better served with CABG 
than with PCI (Patel, Dehmer, Hirshfeld, Smith, & Spertus, 2009a).  In general, CABG 
was rated as appropriate for patients with 3-vessel disease, left main stenosis, regardless 
of multi-vessel status or the presence of diabetes (Patel, et al., 2009a).  PCI was viewed 
as being inappropriate for these patients.  PCI was judged to be appropriate for patients 
with 2-vessel disease with left proximal anterior descending artery stenosis (Cantor, et 
al., 2002), again with or without diabetes.  Overall, CABG was rated more favorably than 
PCI for individuals with diabetes (Patel, et al., 2009a).  However, guidelines for the 
comparative effectiveness of CABG and PCI were developed with clinical evidence from 
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high-risk populations, studies with highly selective patients that may not represent the 
general population (Bourassa, 2000; Detre et al., 1999; Eagle, et al., 2004; King, 1999; 
King, Kosinski, Guyton, Lembo, & Weintraub, 2000; Kip, et al., 2002; Patel, et al., 
2009a; Smith, et al., 2001).  Furthermore, the review of randomized clinical trials and 
registry studies examining revascularization that included patients with diabetes 
conducted by Berry and colleagues (2007) highlighted limitations among many studies, 
including small samples of individuals with diabetes, and lack of information about 
glycemic control or complications of diabetes.  
Revascularization Outcomes 
 
 Considerable research has evaluated long-term effects of revascularization.  Much 
less research has examined short-term effects of revascularization.  Common short-term 
outcomes include procedural adverse events, such as in-hospital mortality, postoperative 
stroke, and renal failure requiring hemodialysis.  The rate of in-hospital mortality after 
CABG varies across studies, in part due to methodological differences (Bittner & Savitt, 
2002; Ellis, et al., 1988; O'Connor, et al., 1991).  Common risk factors for in-hospital 
mortality among CABG and PCI patients include being older or female, having a history 
of peripheral vascular disease or heart surgery, or having renal dysfunction, postoperative 
stroke, or diabetes (Gruberg, et al., 2001; Stamou, et al., 2001).  Both CABG and PCI 
have been associated with greater risk of in-hospital mortality (Eagle, et al., 2004; Smith, 
et al., 2006), although some studies suggest no difference (Berry, et al., 2007; Bravata, et 
al., 2007).   
 The incidence of adverse neurological effects due to cerebral vascular accidents 
(CVA) ranges between 0.05% to 0.38% for PCI (Brown & Topol, 1993; Fuchs, et al., 
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2002), and 0.40% to 0.80% for CABG (Breuer, et al., 1983; McKhann, et al., 1997).  The 
wide ranges for these rates may be attributable in part to differences in the definition of 
CVA, or differences in study designs or research samples.  The CVA definition may be 
restrictive, as in cerebral infarction detected by imaging techniques.  Alternatively, CVA 
may be defined broadly to include transient ischemic attacks and loss of neurological 
function (McKhann, et al., 2006; Smith, et al., 2006).  Stroke and renal dysfunction are 
sequelae of microvascular and macrovascular complications of diabetes and are major 
complications of coronary revascularization, particularly for individuals with 
compromised physiologic and metabolic status associated with diabetes complications, 
such as vessel shrinkage and reduced creatinine clearance (Beckman, et al., 2002; Fuchs, 
et al., 2002; Rosolova, et al., 2008; Schachner, et al., 2005; Vlassara, 1997).  Despite the 
link between diabetes complications and poorer outcomes after CABG and PCI, this 
relationship has received little attention in prior research.  
Revascularization Outcomes among Patients with Diabetes 
 
Epidemiological evidence suggests that the physiologic and metabolic 
dysfunction associated with diabetes contributes to worse outcomes among individuals 
with diabetes and comorbid atherosclerotic disease (Nesto, 2004; Yan, et al., 2003).  
Chronic hyperglycemia, dyslipidemia, and vascular inflammation cause arterial 
dysfunction, severity of arterial stenosis, and more diffuse CAD (Nesto, 2004; Yan, et al., 
2003).  In addition, hyperglycemia causes glycosylation of protein, a precursor to 
diabetes microvascular complications (Vlassara, 1997).  Hyperglycemia is also associated 
with platelet abnormalities, evident in a higher number of pro-coagulating platelets, a risk 
factor for thrombolytic events (Creager, et al., 2003).  Diabetic nephropathy, reduced 
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creatinine clearance, and proteinuria are indicators of long-term poor glycemic control, 
and are associated with poor short and long-term outcomes after coronary 
revascularization (Reeder, et al., 2002).  In addition to metabolic dysfunction, studies 
have suggested coronary artery remodeling, where the vessel dimension compensates to 
changes in atherosclerotic plaque build-up (Barsness, et al., 2005).  This compensation is 
less than optimal in individuals with diabetes (Jiménez-Quevedo, et al., 2009; 
Vavuranakis, et al., 1997).  Coronary arteries of individuals with diabetes lack the 
tendency to compensate for changes caused by arthrosclerosis, which is linked with 
vessel shrinkage, a major risk factor for restenosis and adverse cardiac events after PCI 
(Cantor, et al., 2002; Jiménez-Quevedo, et al., 2009; Mazeika, et al., 2003).  Some studies 
have suggested the optimal control of blood glucose may reduce both mortality and 
illness severity.  Several studies found a significant reduction in mortality due to strict 
perioperative glucose control among patients having CABG (Díaz, et al., 1998; Furnary, 
et al., 2003; Malmberg, et al., 1996).  Anatomical, physiologic and metabolic 
dysfunctions that affect individuals with diabetes are antecedent to diabetes 
complications, and are risk factors for severe CAD and for adverse short-and long-term 
outcomes of CABG and PCI.   
Study Contributions 
 
Despite evidence that poorer revascularization outcomes are associated with 
metabolic changes resulting from suboptimal glycemic control, few research is focused 
on the response to revascularization procedures among individuals with diabetes 
complications.  The present study addresses this gap in the literature and quantifies 
adverse outcomes of diabetes complications among patients having either CABG or PCI.  
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Understanding the experience of individuals with diabetes complications after 
revascularization will help to identify the revascularization strategy that may offer better 
outcomes for patients with CAD and diabetes complications.  The purpose of this study is 
to examine the effect of diabetes complications using three measures of adverse outcomes 
– in-hospital mortality, postoperative stroke, and renal failure – among individuals with 
diabetes having CABG or PCI, using a large nationally representative hospital discharge 
dataset.  This research was guided by two hypotheses: 
 Hypotheses 
 
1: Among individuals with diabetes who have CABG or PCI, those with diabetes 
complications will be more likely to have one or more adverse short-term health 
outcomes.  Adverse short-term outcomes examined in this study are in-hospital mortality, 
postoperative stroke, and renal failure.  The rationale for this hypothesis is: (1) 
Macrovascular and microvascular complications of diabetes are sequelae of prolonged 
hyperglycemia, which is a factor in artherosclerosis and more diffuse CAD, a 
characteristic associated with a poorer prognosis (Abdul-Ghani et al., 2006; Hanssen, 
1997; Silva, Escobar, Collins, Ramee, & White, 1995; Stratton et al., 2000).   (2) 
Metabolic changes due to prolonged hyperglycemia have been shown to reduce 
creatinine clearance, and increase proteinuria, vessel narrowing, and platelet 
abnormalities; all of these are indicators for poor outcomes of coronary revascularization 
(Jiménez-Quevedo, et al., 2009; Reeder, et al., 2002; Vavuranakis, et al., 1997).  (3) 
Studies have also suggested an increased risk for mortality and morbidity in patients with 
uncontrolled diabetes and retinopathy who had coronary revascularization. (Ishihara et 
al., 2005; Malmberg, et al., 1996; Schmeltz et al., 2007).  
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2. Among individuals with diabetes complications, short-term adverse health outcomes 
will be less likely for those having CABG than for those having PCI.  The rationale for 
this hypothesis is: (1) Although studies have suggested more favorable long-term 
outcomes with CABG over PCI, (Berry, et al., 2007) evidence supporting the benefit of 
CABG over PCI in reducing postoperative morbidity and mortality is mixed (Bravata, et 
al., 2007).  (2) Narrowing of coronary vessels, a risk associated with the microvascular 
complications of diabetes has been suggested as a predisposing factor for adverse 
outcomes in angiography (Schunkert, Harrell, & Palacios, 1999).  (3) Contrast-induced 
nephropathy is a complication of the PCI procedure and a risk factor for renal failure, 
especially in patients with vascular abnormalities (Marenzi et al., 2004; Rashid et al., 
2004).  Thus, these factors are likely to increase the risk of adverse outcomes among 
patients with diabetes, especially those with comorbid diabetes complications having 
PCI. 
Design and Methods 
 
Conceptual Framework  
 
 The framework for this study was adapted from the framework developed by 
Shroyer and colleagues in the Process, Structures and Outcomes of Care in Cardiac 
Surgery (PSOCS) study, a modified version of the Donabedian model (Donabedian, 
1966; Shroyer et al., 1995).  The PSOCS model has been used by a number of studies to 
evaluate the relationship between the dimensions of the model and cardiac surgery 
outcomes (Khuri et al., 1999; O'Brien et al., 2004; Rumsfeld et al., 1999).  The PSOCS 
framework has a hierarchical set of interacting dimensions and sub-dimensions, and 
suggests that cardiac surgery outcomes are dependent on the interactions of the 
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process/structure dimensions with characteristics of patients.  Figure 3.1 shows the 
model.  The main dimensions of this framework are patient risk factors, structure, 
process, interval events, and outcomes.  Patient risk factors are characteristics that 
predispose patients to experiencing adverse outcomes.  Structure relates to the staffing, 
physical facilities and equipment, organizational system type, and oversight process.  
Process relates to the type, conduct of the revascularization procedure, and postoperative 
care.  In this study, the type of cardiac surgery refers to CABG and PCI.  Not all patients 
benefit equally from CABG or PCI (Berry, et al., 2007; Bravata, et al., 2007; Eagle, et al., 
2004).  However, good process of care in cardiac surgery includes treating patients with 
the optimal revascularization procedure, which should increase the likelihood for good 
outcomes (O'Keefe, Blackstone, Sergeant, & McCallister, 1998).  This study postulated 
that the optimal revascularization procedure for patients with diabetes complications 
would increase their chances for better outcomes, controlling for the potential effects of 
patient and hospital structure on the process of care and outcomes.   
Data Source 
 
 This is a cross-sectional analysis using data from the 2007 Nationwide Inpatient 
Sample (NIS), hospital discharge data maintained as part of the Healthcare Cost and 
Utilization Project (HCUP) by the Agency for Healthcare Research and Quality (AHRQ) 
(HCUP, 2007).  The NIS is nationally representative administrative data representing all 
inpatient stays from a stratified 20% sample of United States community hospitals 
(HCUP, 2010).  Many quality assurance procedures are performed on the NIS data to 
ensure consistent internal and external validity (HCUP, 2009).  Five nested stratification 
variables based on the characteristics of hospitals from HCUP participating states were 
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used to create sampling strata; discharge sample weights were calculated as the 
probability of sampling within each stratum (HCUP, 2006).  The NIS offers two major 
advantages: a) it provides a large volume of data that allows examination of sub-groups 
defined by ethnicity and other characteristics; and b) the data can be weighted for 
national representation.  The NIS includes four data groups: a) de-identified inpatient 
discharge-level data with information about demographics, admission information, length 
of stay, payer information, procedures and diagnoses; b) hospital-level data on location, 
ownership, bed size, staffing ratio, hospital state, and teaching status; c) inpatient 
discharge-level data on measures of severity and comorbidity; and d) discharge-level 
information on diagnosis and procedure groups.  This study was approved by the 
Institutional Review Board of University of North Carolina at Charlotte. 
Study Sample 
 
 The study sample consists of hospital discharge data for patients age 45 and older 
with diabetes who had a CABG or PCI procedure in 2007 at U.S. community hospitals.  
The sample was restricted to patients age 45 and older because increasing age is 
associated with the use of PCI and CABG and the risks for adverse outcomes after 
revascularization (Brooks, et al., 2000; Magee, et al., 2003; Vavlukis, et al., 2006). In 
addition, 95% of PCI and CABG procedures were performed in patients age 45 and older, 
representing about 97% of all CABG discharges and  95% of all PCI discharges in 2007 
(HCUPnet., 2010).  Patients were included if their hospitalization had one of the 
following International Classification of Diseases, Ninth Revision, Clinical Modification 
(ICD-9-CM) procedure codes: 36.10-36.19, 00.66, and 36.01, 36.02, 36.05-36.07 and any 
diagnosis codes indicating that they had diabetes, shown in Table 3.1.  Patients with 
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diabetes who also had comorbid diabetes with renal, ophthalmic, and neurological 
manifestations; diabetes with peripheral circulatory disorders; uncontrolled diabetes; 
chronic kidney disease; or renal failure were considered to have diabetes complications.  
Of more than 8 million hospital discharges in the 2007 NIS database, 62,101 met the 
selection criteria.  The sample was further restricted by excluding patients who had both 
CABG and PCI during hospitalization (535) (Figure 3.2).  
Outcome Variables 
 
 There were three outcome variables: in-hospital mortality, postoperative renal 
failure requiring hemodialysis, and postoperative stroke.  Postoperative renal failure was 
defined as acute renal failure requiring hemodialysis.  Patients with renal dysfunction 
were identified by the presence of any of these diagnoses for acute renal failure: 584, 
5840, 5845-5849 and procedure code 3995 for hemodialysis.  Patients who had 
postoperative stroke were identified by the presence of any of the following diagnosis 
codes as a secondary diagnosis: 43881-43882, 43889, 4389, 4380, 43850-43853, 43830-
43832, 43840-43842, 43820-43822, 43810-43812, 43819, 99702 (Chu et al., 2009).  
Predictor variables 
 
 The main predictor variable of interest was diabetes complications during 
hospitalization.  Patients with diabetes complications were identified using ICD-9-CM 
diagnosis codes shown in Table 3.1.  Other explanatory variables included demographic 
characteristics, comorbidities, and hospital factors. 
Patient Characteristics  
 
 Patient characteristics were categorized into demographic and clinical 
characteristics.  Demographic characteristics were age, sex, race, median household 
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income, and health insurance.  Table 3.2 shows the definition and coding for each 
variable.  Clinical characteristics included admission type, comorbidities, and measures 
of patients‘ illness severity.  Except for the variable for illness severity, all patient 
characteristic variables were coded as dichotomous variables.  The referent group was the 
group with the lowest risk if there was evidence of relative risk from the literature; 
otherwise the referent group was selected to be the group with the most observations.  For 
age, sex, admission type, and comorbidity variables the referent category was the group 
with the lowest risk.  As listed in Table 3.2, age was categorized into the following 
groups: 45-54 (referent), 55-64, 65-74, and 75 and over.  Elective admission was the 
referent group for admission type.  All clinical and comorbidity variables were coded ―1‖ 
if the condition was present, and ‗0‘ otherwise.  Whites were the referent group for race; 
men for gender; those residing in Zip code areas with median household income of 
$45,000 or more were the referent group for income.  A disease-staging variable was 
computed using an algorithm based on patient‘s diagnoses, the stage of the principal 
diagnosis and the predictive scale for death, length of stay and resource use and included 
in the NIS database as a measure of  illness severity (HCUP, 2005).  This measure was 
analyzed as a continuous variable. 
Comorbidities 
 
 Patient comorbidities were defined based on the approach used to construct the 
Elixhauser Comorbidity Index.  The Elixhauser Comorbidity index includes 30 
comorbidities and has been validated for use with administrative data (Elixhauser, 
Steiner, Harris, & Coffey, 1998; Friedman, Jiang, Elixhauser, & Segal, 2006; 
Stukenborg, Wagner, & Connors, 2001; Yan, Birman-Deych, Radford, Nilasena, & Gage, 
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2005).  The algorithm differentiates between comorbidities and complications due to the 
care process by conservatively considering only secondary diagnosis unrelated to the 
patient assigned diagnosis-related group (DRG).  A secondary diagnosis related to the 
DRG was considered to be a contributor to illness severity rather than a comorbid 
condition.  For example, a patient with valve disorder with a cardiac DRG was not coded 
as having a valve disorder comorbidity, although it is likely that the valve disorder would 
contribute to her or his illness severity.  For this study, separate variables for secondary 
diagnoses related to the DRG were created to indicate markers of illness severity.  Thus, 
in addition to the 30 Elixhauser comorbidities, variables for illness severity were created 
for secondary diagnoses of congestive heart failure, valve disorder, and pulmonary 
disorder.  Each comorbid condition was included in the analyses as a dichotomous 
variable, ―Yes/No.‖  In addition, the total number of comorbid conditions for each patient 
was included in the multivariate analyses to adjust for potential association between 
increasing number of comorbidities and the outcomes.   
Process Factors 
 
 The process factors included revascularization techniques, and myocardial 
preservation strategies are shown in Figure 3.1 (Shroyer, et al., 1995).  The process 
variables included in the models used to determine the risk of adverse outcomes were 
volume of CABG procedures, volume of PCI procedures, use of DES in PCI procedure, 
and use of mammary artery graft in CABG procedure.  According to the recommended 
minimum CABG and PCI volume by the Leapfrog Group, hospitals having less than 450 
annual CABG cases were categorized as low-volume; those having 450 and above were 
categorized as high-volume.  For PCI volume groups, hospitals having less than 400 
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annual PCI cases were categorized as low-volume; those having 400 and above were 
categorized as high-volume (Birkmeyer & Dimick, 2004). 
Structure Factors 
 
The measures for the structure dimension include staffing ratio, facility size, and 
hospital organization, which are shown in Figure 3.1 (Shroyer, et al., 1995).  The 
variables included in the analyses were the hospital‘s teaching status, its location, 
whether it is urban or rural, the size of the hospital measured by bed size, and measures 
of nurse staffing.  For the latter, as shown in Table 3.2, the ratio of registered nurses was 
defined as the percentage of registered nurses among all licensed nurses.  For licensed 
practical nurses (LPNs), the workload ratio was defined as the LPN full time equivalents 
(FTEs) per 1000 adjusted inpatient days.  All of these variables were coded as dummy 
variables except variables for staffing ratio.  The variable for bed size was defined by the 
AHRQ, which categorized hospitals as small, medium, or large, taking into consideration 
the region in which the hospital was located as well the hospital‘s urban or rural location 
and its teaching status (HCUP, 2010), large hospitals were the referent category.  The 
referent group for teaching status was teaching hospital and urban hospitals were the 
reference group for hospital location.  
Statistical Analysis 
 
For each subgroup, differences in characteristics for CABG and PCI patients were 
presented and compared using the t-test for continuous variables and chi-square statistic 
for categorical variables.  To evaluate whether diabetes complications were associated 
with CABG and PCI outcomes, the proportions of outcomes were compared between 
individuals with diabetes who also had diabetes complications and those without diabetes 
36 
 
 
        
complications.  Multivariate logistic regression models examined factors associated with 
the risks of poor health outcomes adjusting for confounders.  In a two-step multivariate 
analysis, the propensity score approach was used to adjust for potential confounders and 
computed propensity-adjusted risk of adverse CABG and PCI outcomes.  
 The propensity score statistical approach has been widely used in studies with 
observational data to assess differences in outcomes of treatment options (Curtis, 
Hammill, Eisenstein, Kramer, & Anstrom, 2007; Li, Zhang, Liu, & Ren, 2009; Rubin, 
1997).  This approach is used to minimize selection bias that may have affected the 
assignment of patients to treatment options.  For this study, patients‘ demographic and 
clinical characteristics, hospital factors, and interaction terms for age and number of 
comorbidities were used to build the propensity score model.  The model assessed the 
probability of receiving CABG instead of PCI.  In building the propensity score model, 
the goal is to include many covariates and proxies for variables that best estimate 
treatment assignment (D'Agostino, 2007; Rubin, 1997).  Hospital state (location), CABG 
and PCI volume for the hospitals, hospital bed size, ratio of registered nurses to all 
nurses, and teaching status were included in the propensity model to adjust for hospital 
level effects and differences in state policy such as certificate of need (CON) that may 
influence CABG and PCI volume (Ho, Ross, Nallamothu, & Krumholz, 2007).  Using the 
inverse probability of treatment weight (IPTW) approach, a propensity score weight for 
CABG patients was computed as the inverse of the propensity score (1/PS), and for PCI 
patients as the inverse of 1 minus the propensity score (1/1-PS) (Curtis, et al., 2007; 
Hirano K, 2001; Rosenbaum PR, 1987).  
 All multivariate logistic regression models included the propensity score weights 
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and a subset of patient related covariates that included age, race gender, illness severity 
and the comorbidities significant in bivariate analysis  (D'Agostino, 2007).  Patients with 
end-stage renal failure were excluded from the analyses for postoperative renal failure 
due to their dependence on hemodialysis.  All analyses included necessary adjustments 
for the complex survey design used to select hospitals for the NIS database, and were 
weighted for national representativeness.  The survey procedures in SAS version 9.2 were 
used to estimate, means, frequencies and odds ratios (SAS Institute, Cary, NC).  Model 
discrimination and goodness of fit were determined using c statistics and Hosmer–
Lemeshow statistics, respectively.  Differences and effects with p<0.05 were considered 
to be statistically significant.  
Results 
 
Patient Characteristics 
 
 The weighted frequencies of the study sample are reported in Table 3.3.  Overall, 
in-hospital mortality rate was 1.60%; postoperative stroke was 1.24%; renal failure was 
0.55%.  Of the 61,566 hospitalizations for patients with diabetes who had CABG or PCI, 
12,979 had diabetes complications, 21.2% of the weighted sample; 48,587 did not have 
diabetes complications, 78.8% of the weighted sample.  PCI was the most common 
revascularization procedure, 71.7% of the weighted sample.  Men were 63.2% of the 
weighted sample.  Those between age 55 and 74 represented about 62.4% of the total 
population.  Patients who were Whites represented 55.3%, Blacks 7.5%, Hispanics 7.5%, 
and Asians/Pacific Islanders 2.1%.   
Unadjusted Results for Patient Characteristics 
  
 Unadjusted results of differences in patient characteristics for those with and 
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without diabetes complications are reported in the data columns at the left of Table 3.4.  
The table also shows differences between the characteristics of CABG patients compared 
to those of PCI patients.  Compared to those without diabetes complications, those who 
had diabetes complications were more likely to have indicators of illness severity: 
significantly, higher mean stage of illness (4.6 compared with 4.4, p<.0001) and more 
severe cardiac related comorbidities (all p<.0001).  The proportion of patients with 
diabetes complications was highest for those 75 and older than those in other race groups.  
Although Whites represented more than half of the study sample, individuals in minority 
ethnic groups were more likely to have diabetes complications. 
 Turning to differences in results associated with revascularization strategies, 
compared to PCI patients, CABG patients were more likely to have higher mean stage of 
illness and more than two comorbidities.  Men were more likely to have CABG, whereas 
women were more likely to have PCI.  Patients having PCI were substantially more likely 
to have had a previous CABG (9.0% vs. 1.3%, p<.0001) and previous PCI (18.6% vs. 
10.3%, p<.000) than patients having CABG.  They were also more likely to have 
emergency admissions (34.8% vs. 21.7, p<.0001).  Health insurance and ethnicity did not 
differ significantly for patients selected for CABG compared to PCI.  Only Blacks had 
substantially higher proportions of patients having PCI compared to CABG (8.2% vs. 
5.8%). 
Unadjusted Results for In-Hospital Morality, Renal Failure, and Stroke 
 
 Table 3.5 shows descriptive results for the three adverse outcome measures for 
patients with and without diabetes complications and for patients having CABG or PCI.  
Unadjusted percentages of patients affected by all three adverse outcomes were 
39 
 
 
        
significantly higher for patients with diabetes complications than for those without 
complications: for in-hospital mortality 2.20 versus 0.98 (p<.0001); for post-operative 
stroke 2.44 versus 1.38 (p<.0001); for post-operative renal failure 1.18 versus 0.12 
(p<.0001).  Similarly, unadjusted rates for all three adverse outcomes were higher for 
patients having CABG compared with those having PCI: in-hospital mortality 1.66 versus 
1.07 (p<.0001), post-operative stroke 2.66 versus 1.18 (p<.0001); post-operative renal 
failure 0.55 versus 0.10 (p<.0001).    
Patient Characteristics Associated with Adverse Health Outcomes 
 
 The adjusted results of factors associated with the odds of adverse outcomes are 
presented in Table 3.6.  For each result, the table shows the odds ratio (OR), 95% 
confidence interval (CI), and p-value.  The propensity-adjusted results for factors 
associated with adverse outcomes for patients with diabetes showed that for in-hospital 
mortality, women had 25% greater odds of in-hospital death (OR 1.25, CI 1.06-1.47).  
Patients with diabetes complications had 62% greater odds of in-hospital death than those 
without complications (OR 1.62, CI 1.37-1.91).  The odds of in-hospital mortality 
increased with age.  Compared to those ages 45 to 54, those who were 74 years and older 
had 186% higher odds of in-hospital death (OR 2.86, CI 2.08-3.93); those in the 65-74 
age group had 66% higher odds (OR 1.66, CI 1.20-2.29).  Congestive heart failure 
(p<.0001), coagulopathy (p<.0001), and electrolyte disorder (p<.0001), were all 
significant predictors of in-hospital mortality.  Compared to hospitals with high PCI 
volume, the odds of in-hospital mortality were 37% higher for patients in hospitals with 
low PCI volume (OR 1.37, CI 1.13-1.67).  Compared to PCI, CABG was associated with 
substantially lower odds of in-hospital death (OR 0.42, CI 0.34-0.57). 
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 Factors predictive of postoperative stroke risk included a CABG procedure (OR 
1.58, CI 1.33-1.89), and increasing age.  Each additional increase in the number of 
comorbidities increased the odds of postoperative stroke by 60% (OR 1.60, CI 1.49-
1.72).  Compared with Whites, individuals in the three ethnic minority groups had higher 
odds of having a stroke: Blacks (OR 1.61, CI 1.28-2.03), Hispanics (OR 1.55, CI 1.20-
1.99), and Asians/Pacific Islanders (OR 1.87, CI 1.16-2.99).  Having diabetes 
complications was not associated with a greater likelihood of postoperative stroke. 
 Diabetes complications were significantly associated with renal dysfunction (OR 
3.03, CI 1.71-5.39).  This was also the case with comorbid coagulopathy (OR 1.89, CI 
1.10-3.25) and electrolyte disorder (OR 2.58, CI 1.48-4.52). Demographic factors were 
not significant predictors.  
Adjusted Results for Effects of Diabetes Complications on CABG and PCI Outcomes 
 
 The adjusted results for the likelihood of adverse outcomes for patients with 
diabetes complications having PCI or CABG are shown in Table 3.7.  Patients with 
diabetes complications had significantly higher odds of in-hospital mortality than those 
without complications with either CABG (OR 1.60, CI 1.22-2.10) or PCI (OR 1.59, CI 
1.27-1.99).  Although patients with diabetes complications also had significantly higher 
odds of renal failure with PCI and CABG, their risk with PCI (OR 4.27, CI 1.60-11.42) 
was much higher.  Diabetes complications were not associated with postoperative stroke 
for either CABG or PCI. 
Discussion 
 
 Given the large volume of revascularization procedures in the United States, it is 
useful to identify patient demographic and clinical characteristics associated with adverse 
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outcomes.  Doing so may help identify patients who may be best served with CABG or 
PCI (Patel, et al., 2009b).  Although both CABG and PCI are effective for treating 
coronary artery disease, not all patients have equal experience with CABG and PCI 
(Berry, et al., 2007; Bravata, et al., 2007).  To better clarify the relative effectiveness of 
CABG and PCI, more research is needed on patient subgroups.  However, this has been a 
challenge in most randomized control trials, which are often limited by inadequate 
statistical power and strict criteria for selecting patients.  Using a large administrative 
dataset from United States community hospitals and focusing on patients with diabetes, 
this study examined how outcomes differ for patients with diabetes complications after 
coronary revascularizations.  Further, using the PSOCS conceptual framework to guide 
the analyses, risk adjustment included patient characteristics, and factors for the process 
and structure of care.  Adjusting for process and hospital factors that may influence 
outcomes minimized the potential for ―lack of robustness of risk-adjustment,‖ a limitation 
often associated with the use of administrative data (DesHarnais, McMahon, 
Wroblewski, & Hogan, 1990; Iezzoni, Shwartz, Ash, Mackiernan, & Hotchkin, 1994). 
 This study tested two hypotheses.  The first hypothesis was that patients with 
diabetes complications would have a higher likelihood of in-hospital mortality, 
postoperative stroke and renal failure than those without diabetes complications.  The 
adjusted results provided partial support for this expectation: patients with diabetes 
complications had a higher likelihood of in-hospital mortality and renal failure (Jones, et 
al., 2008; Kim et al., 2002; Ono et al., 2002).  However, for postoperative stroke, those 
with diabetes complications did not experience significantly worse outcomes than those 
without such complications.  In contrast with prior studies that compared differences 
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between patients with diabetes and those without diabetes, this study focused on those 
with diabetes, comparing outcomes for those with and without diabetes complications.  
As a result, those having CABG or PCI in this study may have been similar in some 
characteristics that influenced the outcome for postoperative stroke.  For example, they 
may have had similar hyperglycemia thresholds, which were not evaluated in this study 
(Puskas et al., 2007; Voll & Auer, 1991).   
 There was partial support for the second hypothesis, that individuals with diabetes 
complications would have better outcomes with CABG than with PCI.  Among patients 
with diabetes complications, those having PCI were substantially more likely to have 
renal failure than those having CABG.  Diabetes complications were associated with 60% 
higher odds of in-hospital mortality with CABG and 59% with PCI, suggesting a similar 
experience with both revascularization procedures.  The risk of postoperative stroke did 
not differ between CABG and PCI.    
 Although there is little guidance from randomized trials on the experience of 
patients with diabetes complications with CABG compared to PCI, consistent with the 
expectation of this study, observational studies have suggested an advantage for CABG 
over PCI for patients with retinopathy and strong indications for renal dysfunctions after 
PCI (Marenzi, et al., 2004; Ohno et al., 2006).  In addition, observational studies 
examining effects of diabetes complications such as hyperglycemia and retinopathy on 
revascularization outcomes have found associations between both complications and 
in-hospital mortality, which are consistent with the results of the present study (Jones, et 
al., 2008; Ono, et al., 2006). 
 Overall, the findings of this study suggest that patients with diabetes 
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complications may be more susceptible to adverse outcomes after coronary 
revascularization, particularly in-hospital death and renal failure.  The results also suggest 
that their likelihood of having renal failure is higher with PCI than with CABG.  Thus, 
more attention should be given to patients who have diabetes complications during 
hospitalizations involving PCI or CABG.  To better clarify the benefits of CABG and 
PCI for patients with diabetes complications, future randomized controlled trials 
examining the comparative effectiveness of CABG and PCI in patients with diabetes 
should also focus on patients with diabetes complications.  Nevertheless, the finding in 
this study of a higher risk for renal failure for PCI than for CABG is useful, particularly 
because the patients who had renal failure following PCI or CABG were not identified as 
having comorbid renal failure prior to the procedure.   
  The main strength of this study comes from using a large nationally representative 
hospital discharge database, which allowed the evaluation of adverse post-operative 
outcomes that occur with relatively low frequency.  The large dataset allowed us to 
compare the experiences of patients with and without diabetes complications.  The 
database also included measures of illness severity and comorbidites, which permitted 
risk adjustment.  Randomized controlled trials often adopt restrictive selection criteria, 
rely on registry data, or include a small number of hospitals.  In contrast, this study used a 
representative sample of United States community hospitals.  The NIS is weighted to 
represent all hospitalizations in the United States.  Thus, the results can be generalized.   
 Several study limitations are acknowledged.  The study relied on administrative 
data that have limited clinical details.  For example, the effect of ejection fraction, left 
main disease status and other clinical measures could not be evaluated.  However, 
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information about several secondary diagnoses was available for assessing the likelihood 
of poor outcomes.  Outcomes and predictor variables were determined from diagnosis 
codes.  If there is systematic error in coding and reporting, the results of the study may be 
biased.  The NIS database has been extensively validated by AHRQ; further, potential 
coding errors are likely to affect both groups equally (Chu, et al., 2009).  In addition, data 
on physician experience and practice preferences were not available; such factors may 
introduce unmeasured selection bias.  To minimize this potential bias, the propensity 
score representing each patient‘s probability of receiving CABG instead of PCI was 
computed, using patient clinical and demographic characteristics and hospital factors; all 
adjusted models included the propensity score to adjust for potential selection bias. 
Implications for Policy and Practice 
 
 This study highlights the potential risks associated with diabetes complications in 
coronary revascularization.  Specifically, for in-hospital mortality and renal dysfunction, 
having diabetes complications increased the risk of these outcomes.  In making routine 
clinical decisions for coronary revascularization, patients and clinicians should consider 
the added risk of diabetes complications.  While this study did not consistently show a 
beneficial advantage of CABG over PCI for patients with diabetes complications, 
findings suggest that PCI may be associated with renal dysfunction.  Adverse renal 
outcomes should be considered when making decisions about revascularization options, 
particularly for patients with diabetes who may have diabetes complications other than 
chronic renal failure.  Although results did not show clear benefits of CABG compared 
with PCI with regard to in-hospital mortality and postoperative stroke, findings suggest 
that regardless of the revascularization strategy, patients with diabetes complications may 
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have higher risks of in-hospital death.  Additional research is needed to determine why 
patients with diabetes complications were more likely to have renal failure with PCI.  As 
studies have indicated, contrast-induced nephropathy is a risk factor for adverse outcomes 
for patients with chronic renal failure.  More research is needed to assess whether 
contrast-induced nephropathy explains the likelihood of renal failure in those having 
diabetes complications other than chronic renal failure.  
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Table 3.1: Criteria Used to Define Outcomes and Explanatory Variables 
Diagnosis and Procedure ICD-9-CM Codes
a
 
Post operative stroke 4380, 43810, 43811, 43812, 43819, 43820, 
43821, 43822, 43830, 43831, 43832, 43840, 
43841, 43842, 43850, 43851, 43852, 43853, 
43881, 43882, 43889, 4389, 99702 
Post operative renal failure
b
 3995 
Coronary artery bypass graft 3610, 3611, 3612, 3613, 3614, 3615, 3616, 
3617, 3618, 3619 
Percutaneous coronary intervention 0066, 3601, 3602, 3605, 3606, 3607  
Diabetes  25000-25033, 64800-64804   
Diabetes complications 25040 - 25093, 5853, 5854, 5855, 5856, 
5859, 586,  
Drug Eluting stent 3607 
Mammary artery graft 3615, 3616 
CABG history V4581 
PCI history V4582 
a
ICD-9-CM _ International Classification of Diseases, 9th Revision, Clinical 
Modification.  
b
Postoperative renal failure requiring hemodialysis; CABG= Coronary 
artery bypass graft; PCI= Percutaneous coronary intervention 
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Table 3.2: Definition of Variable and Coding
a
  
Variable Definition  
  
Gender   Men 
 Women 
  Race Non-Hispanic White  
 Black 
 Hispanic 
 Asian/Pacific Islander 
 Native American/others 
  
Primary payer Medicare 
 Medicaid 
 Private insurance 
 Self-pay 
 Other 
 
Median household 
income
b
 
$45,000 or more 
 $25,000-34,999 
 $35,000-44,999 
 $1-24,999 
  
Admission type Elective 
 Emergency 
 Urgent 
  
Age 45-54 
 55-64 
 65-74 
 74 and over 
  
Comorbidities Conditions diagnosed as secondary to the primary 
diagnosis and  unrelated to the patient assigned 
diagnosis-related group 
Disease staging measure Determined based on illness category, the stage of 
principal diagnosis and the predictive scale for 
death and disease progression  
  
Hospital bed size
c 
Large 
 Medium 
 Small 
 
Teaching status of 
hospital
 
Teaching 
 Nonteaching 
  
Hospital location
d
 Urban 
 Rural 
PCI volume All PCI procedures per hospital 
≥400  High volume 
<400 Low volume 
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CABG volume All CABG procedures per hospital 
≥450  High volume 
<450 Low volume 
Staffing  
Registered nurse Percentage of registered nurses among all licensed 
nurse 
Licensed practitioner 
nurse 
LPN FTEs per 1000 adjusted inpatient days 
a
Source: Nationwide Inpatient Sample, 2007;  
b 
The median household income of the patient's 
ZIP Code of residence; 
c 
See Appendix A for definition; 
d
Hospitals residing in counties with a 
CBSA type of metropolitan were considered urban, while hospitals with a CBSA type of 
micropolitan or non-core were classified as rural; CABG= Coronary artery bypass graft; PCI= 
Percutaneous coronary intervention 
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Table 3.3: Characteristics of Patients with Diabetes Having Revascularization 
Procedures in 2007
a
 
    95% Confidence 
Interval  n=61566 N=304480 % LB UB 
Adverse Outcomes      
Postoperative stroke 985 4869 1.6 1.44 1.76 
In-hospital mortality 760 3776 1.2 1.12 1.36 
Postoperative renal failure 340 1689 0.6 0.24 0.68 
Diabetes complications      
Yes 12979 64093 21.2 21.05 21.93 
No 48587 240387 78.8 78.06 79.84 
Admission type
b
      
Elective 21448 105940 34.8 31.43 38.15 
Urgent 14511 73516 24.1 20.38 27.91 
Emergency 18733 94663 31.1 28.37 33.81 
Revascularization Procedure      
CABG 17442 86232 28.3 26.79 29.85 
PCI 44124 218248 71.7 70.15 73.21 
Prior revascularization      
CABG history 4226 20798 6.8 6.31 7.35 
PCI history 10008 49465 16.3 15.12 17.37 
Demographic Characteristics      
Gender      
Men 38932 192501 63.2 62.54 63.92 
Women 22626 111943 36.8 36.08 37.46 
Age group     
45-54 9602 47557 15.6 15.16 16.08 
55-64 18668 92098 30.3 29.61 30.88 
65-74 19827 97996 32.2 31.65 32.72 
75 and older 13469 66830 22.0 21.24 22.66 
Race
b
      
White 33817 168347 55.3 50.53 60.05 
Black 4702 22856 7.5 5.90 9.11 
Hispanic 4729 22708 7.5 5.36 9.55 
Asians/Pacific Islanders 1383 6488 2.1 2.00 3.59 
Others 2332 11328 3.7 2.24 3.87 
Health Insurance      
Medicare 34048 168537 55.4 53.85 56.86 
Medicaid 3280 16266 5.3 4.60 6.09 
Self 1954 9558 3.1 2.72 3.55 
Private 20056 99253 32.6 30.98 34.22 
Median household income      
$1-24,999 17141 84282 27.7 24.34 31.02 
$25,000-34,999 15512 76333 25.1 22.70 27.44 
$35,000-44,999 14085 69901 23.0 20.95 24.96 
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Table 3.3 (Cont‘d)      
$45,000 or more 13056 65218 21.4 17.22 25.62 
a
 Data source: 2007 Nationwide Inpatient Sample (NIS), weighted results for national 
representativeness.  
b
Percentages may not total 100 because of missing data. CABG=Coronary artery 
bypass graft, PCI=Percutaneous coronary intervention. LB=lower bound, UB=upper bound. The 
percentages   of some categories may not add to 100% due to missing data. 
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Table 3.4: Stratified Demographic and Clinical Characteristics of Patients With Diabetes—
With and Without Diabetes Complications, and With Coronary Artery Bypass Graft 
(CABG) or Percutaneous Coronary Intervention (PCI), 2007
a
 
 Diabetes Complications  Revascularization Procedure 
Variables Yes %   No %   P-value CABG % PCI % P-value 
Clinical Characteristics       
Mean  level of illness stage
b
 
(SD) 
4.6(0.48)  4.4(0.49)   <.0001 4.9(0.16) 4.2 
(0.43) 
<.0001 
Illness severity       
Valve disorder 10.1 6.7 <.0001 10.6 6.2 <.0001 
Severe CHF 25.0 11.7 <.0001 18.9 12.7 <.0001 
Pulmonary hypertension
c
 3.0 1.6 <.0001 2.6 1.6 <.0001 
Emergency admission 34.8 30.1 <.0001 21.7 34.8 <.0001 
CABG history 6.7 6.9 0.6583 1.3 9.0 <.0001 
PCI history 13.4 17.0 <.0001 10.3 18.6 <.0001 
Number of Comorbidities   <.0001   <.0001 
1-2 13.3 47.8  29.4 44.9  
3-5 74.5 50.3  64.5 51.9  
6 and over 12.1 1.9  6.1 3.3  
Demographic Characteristics       
Gender   0.0115   <.0001 
Men 62.1 63.5  68.9 61.0  
Women 37.9 36.5  31.1 39.0  
Age   <.0001   <.0001 
45-54 12.9 16.3  13.4 16.5  
55-64 28.2 30.8  30.7 30.1  
65-74 32.4 32.1  34.6 31.3  
75 and older 26.5 20.7  21.4 22.2  
Race   <.0001   <.0001 
White 53.2 55.9  55.9 55.0  
Black 9.9 6.9  5.8 8.2  
Hispanic 8.2 7.3  7.8 7.3  
Asians/Pacific Islanders 2.5 2..2  2.3 2.1  
Other 3.6 3.8  3.8 3.7  
Health Insurance   <.0001   <.0001 
Medicare 64.7 52.9  54.7 55.8  
Medicaid 5.8 5.2  5.3 5.4  
Private Insurance 24.7 34.7  33.5 32.3  
Self pay 1.9 3.5  2.9 3.3  
Median household income   0.7814   0.0988 
$1-24,999 28.4 28.7  26.8 29.2  
$25,000-34,999 25.8 26.0  26.6 25.5  
$35,000-44,999 23.6 23.8  24.5 23.3  
$45,000 or more 22.2 21.4   22.1 22.0   
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Table 3.4 (Cont‘d) 
a
Data source: 2007 Nationwide Inpatient Sample (NIS); SD=standard deviation; CABG=Coronary artery 
bypass graft; PCI=Percutenous coronary intervention; CHF=Congestive heart failure;
 b
Mean and standard 
deviation;  
c
Includes those with pulmonary embolism. 
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Table 3.5:  Description of Poor Health Outcomes for Patients with Diabetes after 
Coronary Revascularization in 2007
a
 
  Diabetes Complications  Revascularization Strategy 
Outcomes Yes %  No %  P-value CABG %  PCI %  P-value 
In-hospital 
mortality 
2.20 0.98 <.0001 1.66 1.07 <.0001 
Post operative 
stroke 
2.44 1.38 <.0001 2.66 1.18 <.0001 
Post operative 
renal failure 
1.18 0.12 <.0001 0.55 0.10 <.0001 
a 
Data source: 2007 Nationwide Inpatient Sample (NIS). CABG= Coronary artery 
bypass graft, PCI= Percutanenous coronary intervention. 
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Table 3.7: Comparison of Risks for Poor Outcomes Associated with Diabetes 
Complications for CABG and PCI, 2007
a
 
Outcomes 
Revascularization 
strategy 
Odds 
Ratio
b
 
95% CI P-value 
In-hospital mortality     
 CABG 1.60 1.22-2.10 <.0001 
 PCI 1.59 1.27-1.99 <.0001 
Postoperative Stroke     
 CABG 0.96 0.77-1.21 0.7223 
 
 PCI 0.98 0.80-1.22 0.8836 
Post operative renal 
failure 
    
 CABG 2.25 1.10-4.69 0.0311 
 PCI 4.27 1.60-11.42 0.0038 
a
 Data source: 2007 Nationwide Inpatient Sample (NIS).  
b
 Models for each outcome included adjustment for illness severity, age, race, propensity score, use 
of drug eluting stent in PCI and the use of mammary artery graft in CABG.  CABG=Coronary artery 
bypass graft, PCI= Percutaneous coronary intervention; CI=Confidence Interval. 
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Figure 3.1: Graphical Representation of Conceptual Model: from Shroyer et al., 1995 
 
  
Patient Risk Factors
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Figure 3.2: Sample Selection of Patients with Diabetes Having Coronary 
Revascularization in 2007 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8,043,415 hospitalizations representing 20% 
stratified sample of inpatient stay at US 
community hospitals in 2007   
 
186,053 hospitalizations with ICD-9-CM 
codes for CABG and PCI 
Excluded patients without diabetes  
(123,952) 
62,101 
 
61,566 patients with diabetes 
 
Excluded patients with both CABG and PCI 
(535) 
 
 
5
5
 
CHAPTER 4: OFF-PUMP CORONARY ARTERY BYPASS OUTCOMES IN 
PATIENTS WITH DIABETES AND DIABETES COMPLICATIONS 
 
 
Introduction 
 
 Historically, on-pump coronary artery bypass graft (CABG) was the established 
treatment for atherosclerotic heart disease.  Its beneficial effect on survival and overall 
quality of life, especially in patients with severe coronary artery disease (CAD), is well 
documented (Eagle, et al., 2004; Hunt, et al., 2000; Sjoland, et al., 1997).  Nevertheless, 
some complications associated with the on-pump CABG procedure remain a concern.  As 
a result, the use of off-pump CABG as an alternative to on-pump CABG attracted much 
interest because of its potential to minimize the complications and morbidity risks 
associated with the on-pump CABG technique (Cleveland, Shroyer, Chen, Peterson, & 
Grover, 2001; Plomondon et al., 2001).  In general, studies show a trend toward off-pump 
CABG benefits over on-pump CABG in high-risk patients who are older and have 
multiple comorbidities (Chamberlain, Ascione, Reeves, & Angelini, 2002; Meharwal et 
al., 2002).  However, the enthusiasm for off-pump CABG is tempered by inconsistent 
evidence of its advantages over on-pump CABG in reducing perioperative complications, 
ensuring patency of graft in the long-term, and reducing mortality (Parolari et al., 2003; 
Parolari et al., 2005; Patel, Patel, Loulmet, McCabe, & Subramanian, 2004).
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 CAD in persons with diabetes progresses rapidly, and is often more severe and 
diffuse.  Outcomes after coronary revascularization are often worse among individuals 
with diabetes compared to those without diabetes (Flaherty & Davidson, 2005; Nesto, 
2004).  Despite the fact that individuals with diabetes are in a high-risk group, studies 
have not shown differences for people in this group for off-pump compared with on-
pump CABG (Magee, et al., 2001; Srinivasan, et al., 2004).  Diabetes complications are 
indicative of vascular abnormalities caused by metabolic changes due to hyperglycemia 
(Beckman, et al., 2002).  Individuals with comorbid diabetes complications may benefit 
from off-pump CABG because of their elevated risk.  However, the relative efficacy of 
off-pump CABG compared to on-pump CABG in individuals with diabetes 
complications has not been evaluated.  Using a large, nationally representative sample of 
patients with diabetes, the goal of this study is to compare the relative effectiveness of 
off-pump and on-pump CABG strategies among individuals with and without diabetes 
complications.  The findings can help to inform clinical decision making about CABG 
strategies that may be better for individuals with diabetes.  
Overview of Coronary Artery Bypass Graft 
 
 The development of CABG fundamentally changed the treatment of 
atherosclerotic heart disease.  It is the established technique for coronary 
revascularization in patients with severe coronary artery disease (Eagle, et al., 2004; 
Patel, et al., 2009b).  The conventional CABG technique entails stopping the heart and 
using the cardiopulmonary machine to supply blood to the rest of the body during surgery 
(Shekar, 2006).  Studies suggested that the use of cardiopulmonary bypass creates an 
inflammatory response as the blood circulates through the bypass circuit, which increases 
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the risks of perioperative and postoperative complications in on-pump CABG surgery 
(Day & Taylor, 2005).  To reduce these risks, off-pump CABG avoids using 
cardiopulmonary bypass by performing the procedure on a beating heart.  While 
off-pump CABG eliminates the risks associated with cardiopulmonary bypass, without 
cardioplegia the constant motion of the heart can jeopardize graft patency.  In addition, 
there is concern for higher risks of adverse outcomes for patients who begin off-pump 
CABG, but who must be converted to the on-pump procedure (Li et al., 2008).  Clearly, 
both CABG techniques have associated risks.  Recommendations from the International 
Society for Minimally Invasive Cardiothoracic Surgery indicate equivalent perioperative 
morbidity and mortality for on-pump and off-pump CABG; however, the 
recommendations suggest a preference for off-pump CABG for high-risk patients, 
including patients with diabetes (Puskas, et al., 2005).  The review conducted by the 
International Society for Minimally Invasive Cardiothoracic Surgery suggests lower 
morbidity for off-pump compared with on-pump CABG among patients with diabetes 
(Puskas, et al., 2005).  
On-pump and Off-pump CABG outcomes 
 
 Although research has not quantified the proportion of adverse outcomes 
attributable to use of the cardiopulmonary machine, there is evidence that patients having 
the on-pump procedure may be more likely to have complications, including 
postoperative stroke, renal failure, and mortality (Chen-Scarabelli, 2002).  The in-hospital 
mortality rate after on-pump CABG in patients aged 45 and older is between 3.5% to 
4.3%, a risk that is influenced by comorbidities, and perioperative and postoperative 
morbidities (Holmes, et al., 2007).  For example, the mortality risk was twenty times 
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greater for CABG patients who had acute renal failure that required hemodialysis 
compared to those without acute renal failure (Conlon, et al., 1999).  Similarly, stroke 
following on-pump CABG surgery is a serious complication associated with mortality 
(McKhann, et al., 2002; Stamou, et al., 2001).  Further, hemodynamic changes due to 
cardiopulmonary bypass make the kidney susceptible to embolic damage and renal 
failure (Baker, et al., 2001).   
CABG Strategies and Diabetes 
 
 Diabetes is an independent risk factor for CAD.  It accelerates the progression of 
CAD, and coronary artery stenosis, often making patients with diabetes candidates for 
coronary revascularization (Barsness, et al., 2005).  The interest in off-pump CABG has 
grown because of its potential to minimize the risks associated with the bypass process.  
The majority of CABG procedures are performed using the on-pump technique because 
there is still a debate on the superiority of off-pump over on-pump CABG, although some 
studies have suggested that patients with certain risk factors are likely to have better 
outcomes with off-pump CABG (Ascione, et al., 2002; D'Ancona, et al., 2003; Newman, 
et al., 1996).  These risk factors include advanced age, comorbid diabetes, and left 
ventricular dysfunction (Puskas, et al., 2005).  Patients with diabetes are considered high-
risk because CAD in patients with diabetes is more diffuse, involves multiple vessels, and 
often results in more severely occluded vessels with more rupture prone plaques (Cariou, 
et al., 2000; Ledru, et al., 2001; Moreno, et al., 2000).  In addition, metabolic and 
hematologic abnormalities, such as platelet aggregation and poor creatinine clearance, 
elevate the risks for complications and adverse events (Reeder, et al., 2002).   
 Considering these risk factors, patients with diabetes may benefit from the off-
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pump CABG strategy compared to on-pump CABG (Puskas, et al., 2005).  However, 
results from a small number of studies that have examined the efficacy of off-pump 
CABG for individuals with diabetes are mixed and inconclusive (Magee, et al., 2001; 
Srinivasan, et al., 2004).  In a prospective study using the Society of Thoracic Surgeons 
(STS) database, including 2,891 patients with diabetes who had CABG, the off-pump 
procedure was not associated with lower mortality among those with diabetes; patients 
without diabetes did have lower mortality with off-pump CABG than those with diabetes 
(Magee, et al., 2001).  Similarly, in a recent study examining outcomes of off-pump and 
on-pump CABG in patients with diabetes, there was no reduction in mortality for those 
undergoing the off-pump procedure; however, those with the off-pump procedure had 
significantly shorter length of stay, fewer blood transfusions, and less postoperative 
stroke (Srinivasan, et al., 2004).  Srinivasan and colleagues suggested that the lack of a 
significant association between the CABG procedure used and mortality may have been 
due to inadequate statistical power.  They also suggested that unmeasured factors, such as 
staffing issues and hospital characteristics, may have contributed to the results.  In 
addition, effects of comorbid complications of diabetes such as uncontrolled diabetes, 
retinopathy and nephropathy were not assessed, although studies have suggested these 
complications as risk factors for morbidity and mortality after coronary revascularization 
(Jones, et al., 2008; Ono, et al., 2006).  Patients with diabetes complications are a 
high-risk group that may benefit from off-pump CABG (Abraham, et al., 2001; Magee, et 
al., 2001).  
 Research Objectives  
 
 The objective of this study is to compare three outcomes for patients with diabetes 
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who underwent off-pump or on-pump CABG: in-hospital mortality, postoperative stroke, 
and postoperative renal failure.  A related study objective is to determine patient and 
hospital characteristics associated with off-pump CABG outcomes, and to examine 
contextual factors that may be associated with outcomes for patients with comorbid 
diabetes complications.  The results of these analyses will help to further clarify the 
benefits of off-pump CABG in patients with diabetes, and to identify patient and hospital 
characteristics that are associated with adverse outcomes following CABG.  The 
literature supports three hypotheses. 
Hypotheses  
 
1. Compared with on-pump CABG, the off-pump procedure will be associated with lower 
in-hospital mortality, postoperative stroke, and postoperative renal failure. 
The use of off-pump CABG is based on its potential reduction of adverse outcomes, 
especially in high risk patients (Bucerius et al., 2004; Puskas, et al., 2005; Puskas et al., 
2009).  Although evidence supporting these beneficial effects in high risk patients is 
mixed, and varies with the sample studied (Racz et al., 2004; Shroyer, et al., 2009; 
Yokoyama et al., 2000), some studies support a trend for improved outcomes with 
off-pump CABG in patients with diabetes (Abraham, et al., 2001; Magee, et al., 2001; 
Srinivasan, et al., 2004).  Thus, my expectation is that among patients with diabetes 
having CABG, those with the off-pump procedure will have fewer adverse outcomes than 
those with the on-pump procedure.  
2. Teaching hospitals will have fewer poor CABG outcomes.  
Research on quality of care suggests teaching hospitals provide care of better quality and 
have more favorable outcomes, perhaps because the level of expertise, adequacy of 
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staffing and volume of surgical procedures are all higher in teaching hospitals than in 
non-teaching hospitals (Allison et al., 2000; Ayanian, Weissman, Chasan-Taber, & 
Epstein, 1998; Taylor, Whellan, & Sloan, 1999).  Although evidence on the comparative 
benefit of teaching hospitals to non-teaching hospitals on outcomes is mixed (Kuhn, 
Hartz, Krakauer, Bailey, & Rimm, 1994; Simunovic et al., 2000), large volume hospitals 
for CABG are often teaching hospitals (Ross et al., 2010); adherence to standard care 
processes such as aspirin, ACE  inhibitors and β blockers at discharge, is higher in 
teaching hospitals (Allison, et al., 2000).  Teaching hospitals may better manage 
complications, which may result in fewer adverse outcomes (Polanczyk et al., 2002; 
Silber et al., 2009).   
3. Patients with diabetes complications who had off-pump CABG will have lower risks of 
postoperative stroke, postoperative renal failure, and in-hospital mortality than those with 
on-pump CABG.  Patients with diabetes who also have comorbid diabetes complications, 
such as uncontrolled diabetes, renal, ophthalmic, and neurological manifestations, may 
have higher risk of adverse outcomes following coronary revascularization (Ishihara, et 
al., 2005; Marenzi, et al., 2004; Ono, et al., 2006).  Off-pump CABG may minimize risks 
for high-risk patients.  Thus, patients with comorbid diabetes complications may have 
better outcomes with off-pump CABG than with on-pump CABG. 
Design and Methods 
 
Conceptual Framework 
 
 The framework for this study is based on the framework developed by Shroyer 
and colleagues in the Process, Structures and Outcomes of Care in Cardiac Surgery 
(PSOCS) study, a modified version of the Donabedian model (Donabedian, 1966; 
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Shroyer, et al., 1995).  The PSOCS extends the Donabedian model and added patient 
factors, representing individual patient risks that also directly influence outcomes.  The 
structure refers to the hospital setting, location, staffing structure, resources and 
organizational structure.  A good hospital structure encourages an appropriate and quality 
process of care that can potentially minimize patients‘ risks, resulting in better outcomes.  
 As shown in Figure 4.1, cardiac surgery outcomes can be influenced by the 
hierarchical relationship between the dimensions of the PSOCS model.  For example, 
teaching status affords hospitals access to more resources.  Teaching hospitals often have 
higher nursing staffing levels and overall higher staffing quality (Clark et al., 2004).  
Higher staffing levels are associated with lower risks of adverse outcomes (Bloom, 
Alexander, & Nuchols, 1997; Silber, et al., 2009).  In addition, the characteristics of 
patients served by a hospital are related to the hospital location, which consequently may 
influence the hospital‘s case mix (Popescu, Nallamothu, Vaughan-Sarrazin, & Cram, 
2010).  Procedure volume is a structure variable extensively studied for its influence on 
quality of care.  Although the use of CABG volume as a predictor of mortality and a 
proxy for quality of care is not conclusive (Peterson, et al., 2004; Welke, Barnett, 
Sarrazin, & Rosenthal, 2005), studies have suggested that CABG outcomes are better in 
hospitals with high CABG volume compared to low-volume hospitals because high-
volume hospitals are more experienced (Konety, Rosenthal, & Vaughan-Sarrazin, 2009; 
Peterson, et al., 2004).   
 Process variables describe the procedures and care patients received.  The CABG 
procedures are off-pump and on-pump techniques; these techniques do not benefit all 
patient groups equally (Bainbridge, Martin, & Cheng, 2005).  Patient characteristics 
67 
 
        
6
6
 
associated with benefiting from off-pump CABG include older patients, those at high-
risk, and those with multiple comorbidities (Ricci & Salerno, 2006; Stamou et al., 2002).  
Patient characteristics include severity of coronary artery disease, comorbidities, and 
demographic and socioeconomic factors.  Patient risk factors may play an important role 
in the choice of the on-pump or off-pump CABG technique.  Some patient characteristics 
associated with being selected for off-pump CABG include: the need for fewer grafts, 
whether there is stenosis in the left main artery, older age, comorbid diabetes, chronic 
lung disease, and renal failure (Magee, et al., 2003; Magee, et al., 2001). 
Data Source  
 
 This is a cross-sectional analysis using data from the 2007 Nationwide Inpatient 
Sample (NIS), hospital discharge data maintained as part of the Healthcare Cost and 
Utilization Project (HCUP) by the Agency for Healthcare Research and Quality (AHRQ) 
(HCUP, 2007).  The NIS is nationally representative administrative data representing all 
inpatient stays from a stratified 20% sample of United States community hospitals 
(HCUP, 2010).  Many quality assurance procedures are performed on the NIS data to 
ensure consistent internal and external validity (HCUP, 2009).  The 2007 database 
includes about 8 million of discharge records sampled from approximately 90% of all 
hospital discharges in 40 states, weighted to provide national estimates.  Five nested 
stratification variables based on the characteristics of hospitals from HCUP participating 
states were used to create sampling strata; discharge sample weights were calculated as 
the probability of sampling within each stratum (HCUP, 2006).  The NIS includes four 
data groups: a) de-identified inpatient discharge-level data with information about 
demographics, admission information, length of stay, payer information, procedures and 
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diagnoses; b) hospital-level data on location, ownership, bed size, staffing ratio, hospital 
state, and teaching status; c) inpatient discharge-level data on measures of severity and 
comorbidity; and d) discharge-level information on diagnosis and procedure groups.  
Information on hospital characteristics, location, size, staffing, and resources included in 
the NIS database were derived from the American Hospital Association's Annual Survey 
Database (Steiner, Elixhauser, & Schnaier, 2002).  This study was approved by the 
Institutional Review Board of University of North Carolina at Charlotte. 
Study Population 
 The study analysis was restricted to patients age 45 and older who had coronary 
artery bypass graft (CABG) procedures, defined by International Classification of 
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) procedure codes: 36.01, 
36.02, and 36.05-36.07.  The sample was restricted to patients age 45 and older because 
increasing age is associated with both having a CABG procedure and the risks for 
adverse outcomes after revascularization (Brooks, et al., 2000; Magee, et al., 2003; 
Vavlukis, et al., 2006).  About 97% of 2007 discharges involving CABG were for 
patients age 45 and older (HCUPnet., 2010).  There were 49,324 hospitalizations with a 
procedure code for CABG.  Of these, 17,977 (36%) had a diagnosis code indicating 
diabetes (Table 4.1).  Of all patients with diabetes, 14,398 (80%) were identified as 
having had on-pump CABG; i.e., their records included ICD-9-CM procedure codes 3961 
and 3966.  Twenty percent (3,579) had off-pump CABG procedures; these patients were 
identified by the lack of procedure codes 3961 and 3966 (Chu, et al., 2009).  Of those 
with diabetes, 4,494 (25%) had renal, ophthalmic, neurological, diabetes with peripheral 
circulatory disorders, uncontrolled diabetes, or chronic kidney disease; patients who had 
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one or more of these conditions were considered to have comorbid diabetes 
complications. 
Outcomes 
 
 The outcomes assessed in the study were postoperative stroke, postoperative renal 
failure, and in-hospital mortality.  The outcomes were assessed independently, and also 
collectively as a composite of all the outcomes.  In-hospital mortality was defined as 
death during a hospital
 
admission where CABG was performed.  Postoperative stroke was 
determined using a combination of primary and secondary ICD-9-CM diagnosis codes.  
The diagnosis codes are shown in Table 4.1.  The codes for postoperative stroke indicate 
late effects of stroke and postoperative neurological complications.  Postoperative renal 
failure was defined as having acute renal failure with concurrent use of hemodialysis 
during hospitalization, specified by the presence of these procedure codes: 3995, 584, 
5840, 5845, 5846, 5847, 5848, and 5849.  All the outcomes were dummy coded as ―1‖ if 
found in the patient‘s record, ―0‖ otherwise. 
Independent Variables 
 
 The independent variables were selected based on the conceptual model that 
guided this study, and grouped as patient characteristics, process variables, and structure 
variables (Shroyer, et al., 1995).  
Patient Characteristics  
 
 These include demographic variables, medical history, comorbidities, and clinical 
characteristics.  Age was represented in the model as a continuous variable centered at 45 
and measured in decades.  For sex, men are the referent group.  For race and ethnicity, 
the groups are African American or Black (hereafter Black), non-Hispanic white 
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(hereafter White), Hispanic, Asian (includes Pacific Islander) and others (includes Native 
American and mixed race) (Trivedi, Sequist, & Ayanian, 2006).  Dummy variables for 
each race and ethnicity group were included in the models, with an additional dummy 
variable representing those with missing race data.  White was the referent group for race 
and ethnicity.  Health insurance categories were Medicare (referent), Medicaid, self-pay, 
private insurance and other payment source (uninsured and other government program).  
The admission type has three categories, elective (referent), emergency, and urgent.  
Dummy variables for categories of health insurance, admission type and median 
household income were used in the analysis.  Patient‘s use of prophylactic aspirin, 
anticoagulants, anti-inflammatory drugs, and antiplatelets and antithrombotics were 
determined from ICD-9-DM codes.  These variables were included in the analysis 
because of their potential effect on CABG outcomes (Hongo, Ley, Dick, & Yee, 2002; 
Kowey, Taylor, Rials, & Marinchak, 1992).  The variable for length of stay was log 
transformed because of skewed distribution, and included in the model as a continuous 
variable.   
 Patient comorbidities were defined based on the approach used to construct the 
Elixhauser Comorbidity Index.  The Elixhauser Comorbidity index, which includes 30 
comorbidities, has been validated for use with administrative data (Elixhauser, et al., 
1998; Friedman, et al., 2006; Stukenborg, et al., 2001; Yan, et al., 2005).  The algorithm 
differentiates between comorbidities and complications due to the care process, by 
conservatively considering only secondary diagnosis unrelated to diagnosis-related group 
(DRG) assigned to the discharge record.  A secondary diagnosis related to the DRG was 
considered to be a contributor to illness severity rather than a comorbid condition.  In 
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addition to assessing the effect of each comorbid condition, a variable representing the 
sum of comorbidities was created to assess the cumulative effect of comorbidities.  
Clinical characteristics were determined based of diagnosis codes.  Variables for insulin 
dependency and atherosclerotic ascending aorta were dummy coded and included in the 
model because of their potential to influence postoperative stroke and postoperative renal 
failure (Davila-Roman, Kouchoukos, Schechtman, & Barzilai, 1999; Nurozler, Kutlu, & 
Kucuk, 2007; Varga et al., 2004).  
Process Variables  
 
 Process variables represented in the analysis included the CABG strategy 
performed, categorized as off-pump or on-pump (referent).  The internal mammary artery 
graft is a dummy variable, coded 1 if these ICD-9 codes (3615, 3616) were present on the 
record, 0 otherwise.  Procedure volume for off-pump, on-pump and overall CABG 
procedures were computed as the sum of the procedure for each hospital. Due to the 
skewed nature of these variables, the variables were log transformed and included in the 
model as continuous variables.   
Structure Variables  
 
The measures for the structure dimension include staffing ratio, and facility size, 
which are shown in Figure 4.1 (Shroyer, et al., 1995).  The variables included in the 
analyses were the hospital‘s teaching status; its location in an urban or rural area; its bed 
size; and measures of nurse staffing.  For the latter, the ratio of registered nurses was 
defined as the percentage of registered nurses among all licensed nurses.  For licensed 
practical nurses (LPNs), the workload ratio was defined as the LPN full time equivalents 
(FTEs) per 1000 adjusted inpatient days.  All of these variables were coded as dummy 
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variables except variables for staffing ratio.  The variable for bed size was defined by the 
AHRQ, which categorized hospitals as small, medium, or large, taking into consideration 
the region in which the hospital was located as well the hospital‘s urban or rural location 
and its teaching status (HCUP, 2010); large hospitals were the referent category.  
Detailed description of the definition of hospital bed size categories is in Appendix A. 
The referent group for teaching status was teaching hospital.  Urban hospitals were the 
reference group for hospital location.  
Statistical Analysis 
 
 Descriptive analyses included weighted frequencies of the dependent and 
independent variables.  Characteristics were compared between patients with and without 
off-pump use, and between patients who received care at teaching and non-teaching 
hospitals, using the chi-square test for categorical variables and t-test for continuous 
variables.  Using the SAS GLIMMIX procedure for binary dependent variables, 
multilevel analyses was used to identify factors associated with the outcome variables.  
Multilevel modeling is widely used in research estimating adjusted effects with 
contextual variables.  Multilevel analysis accounted for the clustering of patients within 
hospitals, and allowed for accurate calculation of standard errors.  Model fit was 
determined using the ratio of the generalized chi-square statistic and its degrees of 
freedom.  Ratios close to 1 indicate a model with little residual (Schabenberger, 2005).  
Separate models were fit to assess in-hospital mortality, postoperative stroke, 
postoperative renal failure, and the additional outcome indicating that one or more of 
these were present.  The sample was grouped by off-pump and on-pump CABG, and 
models were fit to assess each outcome for off-pump CABG and on-pump CABG 
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patients separately.  All analyses were conducted using SAS 9.2 (SAS Institute, Cary, 
North Carolina) and were weighted for national representativeness.    
Results 
 
Sample Characteristics  
 
 Table 4.2 shows the sample size (n), the weighted population size (N), the 
weighted percent and the confidence interval for the weighted estimate for adverse 
outcomes and selected characteristics for patients with diabetes who had coronary artery 
bypass graft.  Those who died in the hospital represented 1.7% of the weighted sample, 
2.6% had postoperative stroke; and 1% had postoperative renal failure.  Patients with 
diabetes complications represented 25% of those having CABG.  About 80% of patients 
had on-pump CABG.  The remaining 20% had off-pump CABG.  About 55% of patients 
were age 65 or older, White, or Medicare beneficiaries.  
Bivariate Results  
 
Adverse Outcomes 
 
 Table 4.3 reports the percentage of adverse outcomes by CABG strategies, 
diabetes complications status, and hospital teaching status.  For all outcomes, patients 
with diabetes complications had significantly higher rates of adverse outcomes than those 
without diabetes complications: in-hospital mortality (2.7% vs. 1.4%); postoperative 
stroke (3.3% vs. 2.5%); postoperative renal failure (3.5% vs. 0.3%); and the composite 
outcome (8.7% vs. 4.0%).  The proportion of patients who had off-pump CABG and had 
adverse outcomes was not significantly different from those who had on-pump CABG.  
There was no significant difference in the percentage of adverse outcomes among 
patients who had CABG at teaching hospitals compared to those who received care at 
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non-teaching hospitals.  
CABG Strategies  
 
 The results of statistical tests that separately compared characteristics of off-pump 
patients to those having on-pump CABG are presented in Tables 4.4.  The average age 
(65.6 vs. 65.9 p=0.0749), and length of hospital stay (LOS) (9.7 vs. 9.6, p=0.5350) were 
not significantly different between patients in the off-pump or on-pump groups.  
However a higher percentage of patients with the off-pump procedure were women, had 
low median house household income and had an emergency admission.  
Diabetes Complications 
 
 Differences between patients with diabetes complications and those without 
diabetes complications are shown in Table 4.5.  A number of characteristics differed 
among patients with diabetes who had diabetes complications and those that did not have 
diabetes complications.  On average, patients with diabetes complications stayed longer 
in the hospital (11.9 days versus 8.9 days, p<.0001), were slightly older (66.5 versus 
65.7, p<.0001) and had higher average number of comorbidites (4.0 versus 3.1, p<.0001).  
In addition, compared with those without complications, patients with diabetes 
complications were more likely to have had a blood transfusion (5.1% vs. 3.7%, 
p<.0001), to have used insulin (12.4% vs. 8.0%, p<.0001), and to be Blacks (8.0% vs. 
5.1%, p<.0001).  
Teaching and Non-teaching Hospitals 
 
 The results of statistical tests that separately compared characteristics of teaching 
hospitals with those of non-teaching hospitals are presented in Table 4.6.  Although 
measures of staffing between the hospitals were not significantly different, teaching 
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hospitals performed more CABG procedures than non-teaching hospitals.  The average 
volume of all CABG procedures (247.9 vs. 167.4, p<.0001), and the respective average 
volume of total off-pump and on-pump CABG procedures was higher in teaching 
hospitals.  The average length of stay for patients treated at teaching hospitals was 
significantly higher than that for patients in non-teaching hospitals (9.9 vs. 9.3, 
p=<.0001).  
Multivariate Results 
 
 The multilevel analyses focused on associations between the adverse outcomes 
and patients‘ characteristics, exploring the association of process factors and hospital 
characteristics.  The adjusted results of factors associated with in-hospital mortality, 
postoperative stroke, postoperative renal failure, and the composite outcome (either in-
hospital mortality, or postoperative stroke, or postoperative renal failure), with their 
estimated odds ratios (ORs) and 95% confidence intervals (CIs) are presented in tables  
4.7 and 4.8.  
Patient Risk Factors  
 
  Patient risk factors that were associated with the composite outcome included 
longer hospital stay (OR 1.16, CI 1.01-1.33); increasing age (OR 1.17, CI 1.09-1.26); 
wound complications (OR 1.90, CI 1.07-3.36) and the degree of renal dysfunction.  
Further, those with advanced renal dysfunction had greater risk of having one of the 
adverse outcomes represented in the composite variable than those without renal 
dysfunction (OR 2.59, CI 1.55-4.32).  Other risk factors were post surgical hemorrhage 
(OR 1.61, CI 1.18-2.18); congestive heart failure (OR 1.34, CI 1.15-1.57); and a greater 
number of comorbidities (OR 1.18, CI 1.11-1.25).  Compared with Whites, the odds of 
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having one of the composite outcomes were 39% greater for Blacks (OR 1.39, CI 1.06-
1.83) and 42% greater for Hispanics (OR 1.42, CI 1.10-1.84).  
 Most patient factors that were associated with higher odds of having a composite 
outcome were also associated with in-hospital mortality.  An exception was female 
gender.  Compared with men, women had 67% greater odds of death during the hospital 
stay (OR 1.66, CI 1.29-2.17). 
 Patient characteristics that were significantly associated with the risk of 
postoperative renal failure were limited, which may be due to the small number of 
postoperative renal failure cases.  Longer hospital stay (OR 5.07, CI 3.90-6.60), comorbid 
diabetes complications (OR 2.01, CI 1.11-3.63) and coagulopathy (OR 1.64, CI 1.07-
2.50), were associated with postoperative renal failure.  The degree of renal function was 
an important predictor of postoperative failure: patients with poorer renal function were 
particularly at risk (OR 19.68, CI 9.49-41.00).  
 Consistent with the other outcomes, postoperative stroke was associated with 
longer hospital stay.  A greater number of comorbidities and Hispanic ethnicity were 
associated with greater postoperative stroke risk.  Compared to Medicare beneficiaries, 
patients with private insurance were much less likely to have postoperative stroke (OR 
0.58, CI 0.44-0.77). 
Hospital Factors 
 
 Increasing volume of CABG procedure was associated with lower odds of a 
composite outcome (OR 0.86, CI 0.75-0.99) and in-hospital mortality (OR 0.66, CI 0.53-
0.82).  A larger number of  LPN FTEs per 1000 adjusted inpatient days was associated 
with substantially lower odds of in-hospital mortality (OR 0.16, CI 0.03-0.92).  There 
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was no difference in outcomes between patients who had a CABG procedure at teaching 
or non-teaching hospitals.      
Process Factors 
 
 The risk for patients who had off-pump compared to those who had on-pump 
CABG is reported in Table 4.9.  Compared to patients without comorbid diabetes 
complications, those with comorbid diabetes complications who had off-pump CABG did 
not experience significantly lower risks for in-hospital mortality, postoperative stroke, or 
postoperative renal failure.  For patients undergoing on-pump CABG, however, those 
with comorbid diabetes complications had 69% higher odds of post-operative stroke (OR 
1.69, CI 1.10-2.60) and 67% higher odds for the composite outcome (OR 1.67, CI 1.20-
2.32).  
Discussion 
 Off-pump CABG is a relatively safe and effective alternative to on-pump CABG 
(Bainbridge, et al., 2005; Puskas, et al., 2005).  Evidence from research that points to 
benefits of off-pump techniques, especially for patients in high-risk groups, has sparked 
interest in research comparing outcomes among patients undergoing off-pump and 
on-pump CABG.  Interest in this area of research is supported by the expectation that 
off-pump processes should provide benefits for patients for whom the use 
cardiopulmonary bypass is potentially harmful during coronary grafting (Bainbridge, et 
al., 2005).  With advancement in adjunct therapies and coronary grafting techniques, 
patients with higher risk profiles are increasingly candidates for the less invasive 
off-pump CABG technique.  Patients with diabetes are a large and growing group of 
high-risk patients with underlying pathophysiological factors associated with diabetes 
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that predispose then to poorer outcomes following revascularization (Beckman, et al., 
2002; Flaherty & Davidson, 2005).  Some studies have assessed the effect of off-pump 
CABG in patients with diabetes, and have had with mixed results (Abraham, et al., 2001; 
Magee, et al., 2001; Srinivasan, et al., 2004).  However, no previous studies have focused 
on patients with diabetes who have comorbid diabetes complications as a high-risk 
subgroup that may benefit from off-pump CABG.  Diabetes complications indicate 
harmful effects of prolonged hyperglycemia, which is also associated with physiologic 
and metabolic changes that may increase the risk for adverse outcomes with the use of 
cardiopulmonary bypass (Knapik et al., 2009; Marren, 1994).  This study addressed this 
research gap by examining effects of off-pump CABG for patients with diabetes, with a 
focus on outcomes of off-pump versus on-pump techniques among patients with 
comorbid diabetes complications.  As differences among hospitals may affect outcomes, 
the association of structural factors was also examined.  
 Three hypotheses guided this research.  The first hypothesis was that compared 
with on-pump CABG; the off-pump CABG process use would be associated with lower 
risk of in-hospital mortality, postoperative stroke, and postoperative renal failure.  The 
results did not support this hypothesis.  Previous study among patients with diabetes that 
suggested protective effects of off-pump on stroke and renal failure were restricted to 
hospitals participating in a cardiac surgery registry (Magee, et al., 2001), or one cardiac 
center (Srinivasan, et al., 2004).  In contrast, the present study used data from hospitals 
representative of hospitals across the U.S., and is more representative of clinical 
experience, which may explain the differing findings.  In support of this view, studies 
that compared off-pump and on-pump CABG using administrative data, as in the present 
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study, did not find a protective association between off-pump CABG with  postoperative 
stroke and postoperative renal failure, which is consistent with this current study‘s results 
(Chu, et al., 2009; Chukwuemeka et al., 2005).  Systematic differences in contextual 
factors between hospitals, such as surgeon‘s experience and preference, CABG volume, 
and staffing ratios, may also explain some of the differences in outcomes of this study 
and previous studies.   
This study‘s analyses included adjustment for the nested nature of the data and 
potential differences between hospitals that might affect outcomes.  Further, patients with 
diabetes are not a homogeneous group.  The pathophysiologic mechanisms in the 
development of coronary artery disease may be distinct for Type 1 and Type 2 patients 
with insulin-resistance playing an important role in Type 1 diabetes (Orchard et al., 2003) 
with associated risks and the likelihood for poorer outcomes (Luciani et al., 2003).  While 
the analyses in this study adjusted for insulin use, information on insulin use was 
obtained from diagnosis codes and may not reflect an accurate count of all patients who 
were insulin-dependent.  
 The second hypothesis was that patients who had CABG in teaching hospitals 
would have better outcomes than those in non-teaching hospitals.  There were no 
differences in outcomes between teaching and non-teaching hospitals; thus, this 
expectation was not supported.  Although, no specific study has assessed differences in 
outcomes of CABG strategies in teaching and non-teaching hospitals, studies have 
suggested that processes of care such as adjunct therapy like the use of 
angiotensin-converting enzyme inhibitors, aspirin and β-blockers in the management of 
myocardial infarction, a risk factor for mortality and morbidity after CABG is higher at 
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teaching hospitals (Allison, et al., 2000; Rosenthal, Harper, Quinn, & Cooper, 1997).   A 
higher volume of CABG procedures, a measure of quality, is associated with better 
surgical outcomes and is often higher at teaching hospitals than non-teaching hospitals 
(Urbach & Baxter, 2004).  As shown in this study‘s results, the volume of overall CABG 
procedures and respective volume of off-pump and on-pump CABG procedures were 
higher for teaching hospitals.  Despite these results, patients in teaching hospitals did not 
have lower risk of adverse outcomes.  Patients with high illness severity are more likely 
to receive care at teaching than non-teaching hospitals (Iezzoni et al., 1990).  The lack of 
significant benefit associated with teaching hospitals observed in this study‘s results may 
be due to unmeasured illness acuity that reduced potential benefits of better care 
processes in teaching hospitals.  
 The third hypothesis was that patients with diabetes complications who had 
off-pump CABG would have lower risks of in-hospital mortality, postoperative stroke, 
and postoperative renal failure than those who had on-pump CABG.  The results 
suggested that patients with diabetes complications who had off-pump CABG did not 
have significantly lower risk of these adverse outcomes.  Thus, the third hypothesis was 
not supported.  Prior studies that suggested a protective effect of off-pump CABG on 
postoperative adverse complications did not assess outcomes in patients with diabetes 
(Al-Ruzzeh, Ambler, et al., 2003; Al-Ruzzeh, Nakamura, et al., 2003; Bucerius, et al., 
2004; Stamou, et al., 2002).  In contrast, patients selected for this study were restricted to 
those who had diabetes; these patients are likely to have different risks for coronary 
arthrosclerosis from the general CABG population (Flaherty & Davidson, 2005; 
Zornitzki, et al., 2007); their experience with off-pump CABG may be different from that 
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of general CABG patients.  The finding for in-hospital mortality in the present study was 
similar to results from previous research in patients with diabetes (Magee, et al., 2001; 
Srinivasan, et al., 2004).   Additionally, differences in methods and unmeasured 
differences in adjuvant care therapy may further explain some of the variations.  Other 
factors other than CABG strategies have also been suggested as more important in 
predicting postoperative stroke and postoperative renal failure (Marasco, Sharwood, & 
Abramson, 2008; Selnes et al., 2005).  The findings of the present study indicate that the 
degree of renal function was a strong predictor of postoperative renal failure.  Further, 
Hispanic ethnicity, a greater number of comorbidities, and regional location were some of 
the few factors associated with greater risks of postoperative stroke. 
 Although the present study suggests that off-pump CABG and teaching status had 
no significant protective effect on in-hospital mortality, postoperative stroke, and 
postoperative renal failure, the results suggested that patient risks factors may be better 
predictors of these outcomes than process and structure factors.  Patient risk factors that 
were associated with in-hospital mortality and the composite outcome included greater 
age, being female, post surgical hemorrhage, wound complications, congestive heart 
failure, a greater number of comorbidities, and advanced stages of renal impairment.  
Further, structural factors such as increasing volume of CABG procedures and a greater 
number of licensed practical nurse full-time equivalents (LPN FTEs) per 1000 adjusted 
inpatient days reduced the risk of in-hospital mortality and the composite outcome.  
 The main strength of this study came from using a large nationally representative 
hospital discharge database, which allowed the evaluation of adverse post-operative 
outcomes that occur with relatively low frequency.  The large dataset allowed us to 
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compare the experiences of patients with and without diabetes complications.  The 
database also included measures of illness severity and comorbidites, which permitted 
risk adjustment.  Randomized controlled trials often adopt restrictive selection criteria, 
rely on registry data, and include a small number of hospitals.  In contrast, this study used 
a representative sample of United States community hospitals.  The NIS is weighted to 
represent all hospitalizations in the United States.  Thus, the results can be generalized.   
 Several study limitations are acknowledged.  The study relied on administrative 
data that have limited clinical details.  For instance, the effect of ejection fraction left 
main disease status and other clinical measures could not be evaluated.  However, 
information about several secondary diagnoses was available for assessing the likelihood 
of poor outcomes.  Outcomes and predictor variables were determined from diagnosis 
codes.  If there is systematic error in coding and reporting, the results of the study may be 
biased.  The NIS database was extensively validated by the Agency for Healthcare 
Research and Quality; potential coding errors are likely to affect both groups equally 
(Chu, et al., 2009).  Further, data on physician‘s practice preferences was not available; 
such factors may introduce unmeasured selection bias.  As this analysis was restricted to 
events occurring during hospitalization, we did not account for potential adverse 
outcomes related to the surgical procedure that occurred after discharge.  This study was 
a retrospective analysis of cross-sectional data, which precludes establishing causal 
relationships.  The lack of adjustment for conversion from off-pump to on-pump is also a 
limitation.  Surgical experience and preference in selecting patients for either CABG 
strategy have been suggested to play a role in surgical outcomes (Mitka, 2004).  This 
information was not available in the data, and was not evaluated.  However, conducting 
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multilevel analyses, which accounted for differences in hospital characteristics, should 
have reduced the potential effect of this limitation.  In addition, there were a small 
number of cases with renal failure, especially among patients who had off-pump CABG.  
The analysis may not be adequately powered to detect a significant association between 
off-pump CABG and outcomes in off-pump CABG patients. 
Implications for Policy and Research 
 Patients with diabetes complications were significantly different from those 
without complications.  Some indicators of adverse outcomes were more common among 
patients with diabetes complications, such as receiving blood transfusion, having wound 
complications, having atrial fibrillation, or having comorbid valve disorder.  Considering 
these risks, it may be useful to give more attention to patients with comorbid diabetes 
complications during and after CABG procedures, to minimize the potential effect of 
these risk factors.  
 Although process and structure variables are important in measuring outcomes, 
the results suggest that patient risk factors were stronger in determining outcomes in 
patients with diabetes having CABG.  Thus, it is useful for health care providers to assess 
these risks in patients before and while in the hospital.  For example, post surgical 
hemorrhage was associated with higher odds of having a composite outcome.  Assessing 
for surgical hemorrhage post CABG and providing prompt intervention may mitigate 
detrimental effects.  While this study did not show a support for a benefit of off-pump 
CABG in reducing short-term poor outcomes in patients with diabetes, it supports other 
published research that suggested equivalent effect for both CABG strategies with 
regards to short-term outcomes.  Both CABG strategies should be considered in selecting 
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patients with diabetes for coronary bypass grafting.  However, more emphasis should be 
on patient risk factors as they may be more predictive of poor outcomes.      
 High volume of CABG procedures had a protective effect on the likelihood of 
having the study‘s outcomes. This supports existing evidence on the protective effect of 
procedure volume and further provided support in a high-risk group.  Although not 
assessed in this study, surgeon‘s specialization in off-pump CABG may be important in 
deriving a benefit with off-pump CABG in patients with diabetes because they are often 
complex patients with multiple comorbidities.  Further, women were at higher risk for in-
hospital mortality than men, and were more likely to have off-pump than on-pump 
CABG.  Some studies have suggested that the off-pump procedure may benefit women; 
future research should assess this potential benefit for women with diabetes.  
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Table 4.1: Criteria Used to Define Outcomes and Explanatory Variables 
Diagnosis and Procedure ICD-9-CM Codes
a
 
Post operative stroke 4380, 43810, 43811, 43812, 43819, 43820, 
43821, 43822, 43830, 43831, 43832, 43840, 
43841, 43842, 43850, 43851, 43852, 43853, 
43881, 43882, 43889, 4389, 99702 
Hemodialysis 3995 
Postoperative renal failure Hemodialysis and ARF codes 
Coronary artery bypass graft 3610, 3611, 3612, 3613, 3614, 3615, 3616, 
3617, 3618, 3619 
Percutaneous coronary intervention 0066, 3601, 3602, 3605, 3606, 3607  
Diabetes  25000-25033, 64800-64804   
Diabetes complications 25040 - 25093, 7751, 5853, 5854, 5855, 5856, 
5859, 586, V420, V451 
Drug Eluting stent 3607 
Mammary artery graft 3615, 3616 
CABG history V4581 
PCI history V4582 
Long-term /use of 
antiplatelets/antithrombotics 
V5863 
Long-term / use of nonsteroidal anti-
inflammatories 
V5864 
Long-term / use of insulin V5867 
Long-term /current use of aspirin V5866 
Long-term / use of anticoagulants V5861 
Atherosclerotic ascending aorta 4400 
Acute renal failure (ARF) 584,5840, 5845,5846, 5847,5848, 5849 
a
ICD-9-CM _ International Classification of Diseases, 9th Revision, Clinical Modification.  
b
Postoperative 
renal failure requiring hemodialysis.  
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Table 4.2: Characteristics of Patients with Diabetes Having Coronary Artery 
Bypass Graft Procedure in 2007
a
 
Parameters   95% Confidence 
Interval  n=17975 N=88848 % LB UB 
Adverse Outcomes      
Postoperative stroke 466 2337 2.6 2.29 2.96 
In-hospital mortality 303 3776 1.7 1.47 1.95 
Postoperative renal failure 193 980 1.0 0.88 1.32 
Diabetes complications      
Yes 4494 22217 25.0 23.65 26.35 
No 13483 66631 75.0 73.64 76.34 
Admission type
b
      
Elective 7759 38593 43.4 39.97 46.9 
Urgent 4033 20457 23.0 19.37 26.67 
Emergency 3934 19817 22.3 19.84 24.76 
CABG Strategy      
On-pump 14346 71201 80.1 76.58 83.69 
Off- pump 3631 17647 19.9 16.31 23.41 
Demographic Characteristics   
Gender      
Men 12389 61161 68.8 68.01 69.67 
Women 5587 27683 31.2 30.32 31.99 
Age group     
45-54 2459 12112 13.6 13.01 14.26 
55-64 5526 61590 30.7 29.72 31.64 
65-74 6212 30636 34.5 33.64 35.36 
75 and older 3780 18842 21.2 20.12 22.29 
Race
b
      
White 9969 49767 56.0 50.63 61.39 
Black 1062 5127 5.8 4.34 7.19 
Hispanic 1448 6935 7.8 4.99 10.61 
Asian 441 2050 2.3 1.56 3.05 
Others 673 3297 3.2 2.67 4.75 
Health Insurance      
Medicare 9780 48337 54.4 52.83 55.98 
Medicaid 945 4669 5.3 4.31 6.2 
Self 542 2614 2.9 2.46 3.43 
Private 5978 29665 33.4 31.79 34.99 
Median household income      
$1-24,999 4716 23083 26.0 22.41 29.55 
$25,000-34,999 4693 22949 25.8 23.16 28.49 
$35,000-44,999 4256 21108 23.8 21.48 26.04 
$45,000 or more 3772 19056 21.5 17.18 25.71 
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Table 4.2 (Cont‘d) 
a
 Data source: 2007 Nationwide Inpatient Sample (NIS), weighted results for national 
representativeness.  
b
Percentages may not total 100 because of missing data. CABG=Coronary 
artery bypass graft, PCI=Percutaneous coronary intervention. LB=lower bound, UB=upper bound. 
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Table 4.4: Stratified Demographic and Clinical Characteristics of Patients With 
Diabetes—With Off-pump and With On-pump Coronary Artery Bypass Graft 
(CABG), 2007
a
 
Risk factors CABG Strategies  
 Off-pump On-pump P-value 
Age   65.6±9.8 65.9±9.5 0.0749 
Length of stay
b
 9.7± 8.5 9.6 ± 6.8 0.5350 
Number of  comorbidities 3.3 ± 1.3 3.3 ± 1.3 0.4995 
Hypertension 76.7 79.2 0.0451 
Valve disorder 11.2 14.3 0.0058 
CHF 24.9 24.4 0.7512 
Coagulopathy 7.3 9.4 0.0182 
COPD 21.8 20.3 0.1611 
Diabetes complications 25.6 24.9 0.5404 
Peripheral vascular disease 16.3 14.6 0.0589 
Emergency admission 34.8 30.1 <.0001 
Women 33.2 30.7 0.0090 
Income $1-24,999 30.0 25.0 0.0356 
a
Data source: 2007 Nationwide Inpatient Sample (NIS); SD=standard deviation; CABG=Coronary 
artery bypass graft; COPD=Chronic obstructive pulmonary disorder; CHF=Congestive heart failure; 
b
Mean and standard deviation.   
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Table 4.5: Stratified Demographic and Clinical Characteristics of Patients With 
Diabetes—With Diabetes Complications and Without Complications who had 
Coronary Artery Bypass Graft (CABG) 
a
, 2007
b
  
Risk factors Diabetes Complications 
  Yes %  No %  p-Value 
Length of stay
c
 11.9 ± 10.2 8.9 ±  5.6 <.0001 
Age
c
   66.5  ± 9.8 65.7  ±  9.8 <.0001 
Number of  comorbidities
c
 4.0 ± 1.4 3.1 ± 1.2 <.0001 
Blood Transfusion 5.1 3.7 0.0035 
Hypertension 76.7 79.4 0.0105 
Wound complications 0.9 0.6 0.0164 
Atrial fibrillation 28.4 26.1 0.0033 
Valve disorder 16.0 12.9 <.0001 
Had off-pump CABG 20.0 19.4 0.5404 
Coagulopathy 11.3 8.2 <.0001 
History of insulin use 12.4 8.0 <.0001 
Electrolyte disorder 26.1 17.1    <.0001 
CHF 35.8 20.7 <.0001 
COPD 22.3 20.0 0.0025 
Peripheral vascular disease 18.7 13.7 <.0001 
Emergency admission 24.6 21.5 0.0017 
Women 32.3 30.8 0.0990 
Private insurance 27.3 35.4 <.0001 
Self Pay 2.0 3.3 <.0001 
Medicare 61.2 52.1 <.0001 
Black  8.0 5.1 <.0001 
a
 Table reports only factors that were significantly different .
 b
 Data source: 2007 Nationwide 
Inpatient Sample (NIS);. 
c
Mean and standard deviation.  CABG=Coronary artery bypass graft; 
COPD=Chronic obstructive pulmonary disorder; CHF=Congestive heart failure;  
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Table 4.6: The Differences in Hospital Characteristics by Hospital Teaching Status 
2007
a
  
Parameters Teaching  Non-teaching P-value 
Length of stay 
b
 9.9 ± 7.6  9.3 ± 6.4   <.0001 
Age   65.7 ± 9.6   66.2 ± 9.6 <.0001 
LPN FTE
 c
 0.34 ± 0.4   0.4 ± 0.4   0.1423 
RN FTE
 d
 4.3 ± 1.4   4.1 ± 1.23   0.1349 
% of RN
 e
 92.6 ± 7.4   90.8 ± 6.43  0.0631 
CABG volume 247.9 ± 191.4   167.4 ± 131.2  
(0.43) 
0.0002 
Off-pump CABG  volume 50.9 ± 74.4   38.5 ± 5 .0   0.1441 
On-pump   CABG 
volume 
197 ± 162.7   128.9 ± 119.1  
(0.43) 
0.0003 
Urban location 95.3 92.2 0.2641 
Hospital Bed-size 
   
Small 10.6 5.2 <.0001 
Medium 30.8 21.2 <.0001 
Large 58.6 73.7 <.0001 
Region 
   
North East 22.2 7.2 <.0001 
Mid-West 34 29.9 0.0155 
South 29.6 36.8 <.0001 
West 14.2 26.2 <.0001 
a
Data source: 2007 Nationwide Inpatient Sample (NIS); SD=standard deviation; CABG=Coronary 
artery bypass graft; CHF=Congestive heart failure; 
b
Mean and standard deviation;  
b
The number of 
licensed practical nurse full-time equivalents (LPN FTEs) per 1000 adjusted inpatient days;  
 c
The 
number of licensed practical nurse full-time equivalents ( RN FTEs) per 1000 adjusted ;  
 d
The 
percentage of registered nurses among all licensed nurses  (RN & LPN).  
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Table 4.9: The Risk for Patients with Diabetes Complications, Comparing Off-pump 
and On-pump Coronary Artery Bypass Graft (CABG), 2007
a
 
Outcomes Off-pump CABG On-pump CABG 
 OR LB UB P-value OR LB UB P-value 
In-hospital 
mortality 
0.82 0.33 2.02 0.6638 1.41 0.71 2.81 0.3205 
Post operative 
stroke 
0.73 0.37 1.44 0.3647 1.69 1.10 2.60 0.0167 
Post operative 
renal failure 
2.71 0.69 10.58 0.1521 2.32 0.97 5.53 0.0572 
Composite 
endpoint 
0.81 0.46 1.43 0.4673 1.67 1.20 2.32 0.0023 
a
 Data source: 2007 Nationwide Inpatient Sample (NIS). CABG= Coronary artery 
bypass graft. 
97 
 
        
9
6
 
 
Figure 4.1: Graphical Representation of Conceptual Model: from Shroyer et al., 1995 
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CHAPTER 5: READMISSIONS FOLLOWING CORONARY 
REVASCULARIZATION AMONG PATIENTS WITH DIABETES: EFFECTS OF 
DISCHARGE DISPOSITION 
 
 
Introduction 
 
 Health care expenditures in the United States continue to grow, accounting for 
over 16% of the national gross domestic product (GDP) in 2008 (Kaiser, 2011).  Hospital 
readmissions have been proposed as one of the reasons health care costs in the U.S. are 
growing.  Reducing readmission rates gained prominence during the discussions of the 
recent health care policy reform (U.S.Senate, 2009).  Among patients insured by 
Medicare in 2005, readmission rates ranged between 6.2% for early readmissions, those  
occurring within 7 days of discharge, and  17.6% for 30-day readmissions (MEDPAC, 
2007), those occurring between 8 and 30 days of discharge.  In 2009, the estimated rate 
of readmissions within 30 days of discharge was 19.6% (Jencks, Williams, & Coleman, 
2009).  The potential savings from reducing readmissions among Medicare beneficiaries 
over a 10-year period has been estimated at more than $8 billion (Manchikanti & Hirsch, 
2009).  The Centers for Medicare & Medicaid Services (CMS) Hospital Inpatient Quality 
Reporting (IQR) Program added reporting of readmission rates in 2009 (CMS, 2009).  
This inclusion provides an incentive for hospitals to improve hospital efficiency, enhance 
care and discharge planning, and reduce complications of care—all of which may 
contribute to controlling readmission rates (QualityNet, 2011).  
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This study focuses on readmissions for patients who have had coronary artery 
bypass graft (CABG) or percutaneous coronary intervention (PCI).  CABG and PCI 
differ in complexity, but it is known that patients having these procedures are at risk for 
readmission (Curtis et al., 2009; Stewart et al., 2000; Takahashi et al., 2001).  CABG is a 
more invasive procedure than PCI, but 30-day readmission rates for these procedures are 
similar, about 15% for PCI (Curtis, et al., 2009) and about 16% for CABG (Hannan et al., 
2003; Stewart, et al., 2000).  Comorbid conditions are generally associated with  
readmission rates, with multiple comorbidities predicting higher readmission rates 
(Friedman, Jiang, & Elixhauser, 2008).  Congestive heart failure, diabetes or diabetes 
complications, and complications from bypass grafts are among the top illnesses 
identified during the index admission that may increase the probability of readmission 
(Friedman, et al., 2008; Krumholz et al., 2000).  Improved follow-up care after hospital 
discharge can also reduce readmission (Harrison, Hara, Pope, Young, & Rula, 2010; 
Manning, 2011).  Post discharge care includes informal care received at home, formal 
home-care services, and care received at a transitional care facility (TCF).  Research has 
suggested an association between these sources of post-discharge care and lower 
readmission rates.  The purpose of this study was to examine early (≤10 days) and late 
(>10 days) readmissions that occurred within 30-day of discharge in patients with 
diabetes who had coronary revascularization.  Understanding patient characteristics and 
other factors present during the index hospitalization that are associated with readmission 
after revascularization can help to identify factors to be addressed by effective follow-up 
care, thus reducing readmissions.  
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Overview of Readmissions 
 
 There is lack of consensus on a definition of a readmission (Minott, 2009).  The 
terms ―readmission‖ and ―rehospitalization‖ are used interchangeably.  Both terms refer 
to a repeat hospital admission following a discharge.  Readmissions may be categorized 
as unavoidable or avoidable, where the latter are due to adverse events that occurred 
during the index admission, care during the index admission that did not adequately 
prepare the patient for discharge, poor discharge planning, or poor follow-up care (CRS, 
2010; Lin, Chung, Casey, & Snow, 2007; Minott, 2009).  It is often difficult to link 
subsequent admissions to the index hospitalization because of potential effects of 
intervening variables (Clarke, 1990).  In practice, readmissions are typically defined as 
acute care hospitalizations following prior acute care admissions within a specified time 
interval (Goldfield et al., 2008).   
Although there is a lack of consensus on the definition of a readmission, there is 
consensus about the negative impact of readmissions.  In addition to their costs, 
readmitted patients are at greater risk for nosocomial infection and other iatrogenic 
problems, falls or other accidents, and death (Boyce, 1998; Curtis, et al., 2009; Hannan, 
et al., 2003; Jarvis et al., 1991).  Thus, there is considerable interest and research on how 
to predict and reduce readmissions.  This need is particularly great for patients having 
surgical treatment for coronary artery disease, who have a higher readmission risk.  
Coronary Revascularization and Readmissions 
 
 Outcomes of coronary revascularization have been widely studied due in part to 
the complexity of the procedures, the volume, costs, and the characteristics of patients 
who are often candidates for revascularization.  Revascularization outcomes are 
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evaluated to identify risks, to minimize adverse events, and to improve quality of care.  
While considerable efforts have been devoted to outcomes such as mortality, morbidity, 
and the need for repeat revascularization, research on readmission is limited.  Most prior 
research on readmissions related to coronary revascularization has focused on patients 
having CABG.  Very few studies have examined readmissions following PCI, although 
the number of PCIs in the U.S. is growing (Smith et al., 2006).   
Readmission rates vary by time interval, with readmission risk increasing with 
time following the index hospitalization.  The rate of 30-day readmission after discharge 
following CABG has been estimated to be 16%; the corresponding 60-day readmission 
estimate is 18% (Cowper et al., 1997; Stewart, et al., 2000).  In contrast, the estimated 
readmission rate for PCI patients was 14.6% within 30 days of discharge, and 48% within 
one year (Curtis, et al., 2009; Halon, Rennert, Flugelman, Jaffe, & Lewis, 2002).   
 Although readmission rates vary due to the heterogeneity of patients and their 
measured and unmeasured risk profiles, studies have suggested some factors that are 
consistently associated with readmissions.  These factors include older age, multiple 
comorbidities, diabetes, illness severity, being female, being African American, and 
having surgical complications (Beggs, Birkemeyer, Nugent, Dacey, & O'Connor, 1996; 
Ferraris, Ferraris, Harmon, & Evans, 2001; Hannan, et al., 2003; Slamowicz, Erbas, 
Sundararajan, & Dharmage, 2008; Stewart, et al., 2000).  In a follow-up study of patients 
who had isolated primary CABG, the risk of readmission was 22% greater for those with 
diabetes and only 12% for others (Stewart, et al., 2000).  Further, among low-risk CABG 
patients, 28% of those with diabetes were readmitted, compared to 21% of others (Sun et 
al., 2008).  The association of diabetes with readmissions has also been found for PCI 
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patients (Curtis, et al., 2009), especially those with sub-optimal glycemic control (Corpus 
et al., 2004; Moss, Klein, & Klein, 1999).   
 Post-discharge care may also influence readmission.  Increasingly, patients are 
discharged to transitional care facilities to reduce inpatient care costs.  Facilities 
providing transitional care include special units within the hospital, post-acute skilled 
nursing facilities, intermediate care facilities and rehabilitation facilities (AGS, 2007; 
Naylor & Keating, 2008; Naylor, 2006).  From 1990-1998 CABG discharge from a 
medical center to transitional care increased by 40%, discharges with home care services 
increased by 32%, and discharge to home without home care decreased by 42% (Lazar et 
al., 2001).  Understanding whether discharge disposition affects readmission may help 
to improve discharge planning.  
Measures of Readmissions 
 
Most studies of readmissions after revascularization procedures limit their 
analyses to 30-day or within 1-year readmission window (Curtis, et al., 2009; Slamowicz, 
et al., 2008; Stewart, et al., 2000; Sun, et al., 2008).  While some studies have evaluated 
readmissions for a longer duration after the index admission (Herlitz et al., 1997), there is 
concern that surgical related readmission more than 30 days after discharge has less to do 
with the care received during the index hospitalization and more with other factors (CMS, 
2011).  Some research has suggested that studying late readmissions may help to identify 
readmissions preventable through ambulatory care (Benbassat & Taragin, 2000).  
However, shorter duration is preferable for assessing quality of care during the index 
hospitalization, and for comparing effects of surgical care on readmissions (CMS, 2011; 
Sibbritt, 1995).  
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 Reducing Readmission 
 
 Although some risk factors such as race, gender and socioeconomic status are not 
modifiable, understanding whether such risk factors are independently associated with 
readmissions would help to identify characteristics of patients who are at higher 
readmission risk.  Some preventive measures at the point of care include focused 
monitoring of at-risk patients, better care transition from inpatient to outpatient care, and 
better coordination of care between inpatient and primary care providers (Greenwald & 
Jack, 2009).  Further, whether the patient is discharged to home without provision for 
home care services, to home with home care services, or to transitional care, may 
influence the risk for readmission (Bohmer, Newell, & Torchiana, 2002).  Little research 
has examined effects of discharge disposition on readmission risk for patients having PCI 
or CABG.  
Research Objectives  
 
 The objective of this study was to assess 30-day readmissions, categorized into 
early (≤10 days) and late (11 to 30 days) readmission for patients with diabetes who had 
coronary revascularization.  Focusing the analysis on patients with diabetes is useful as 
studies have consistently found that diabetes predicts readmissions (Ferraris, et al., 2001; 
Jiang, Andrews, Stryer, & Friedman, 2005; Stewart, et al., 2000; Sun, et al., 2008; Whang 
& Bigger, 2000).  In addition, diabetes is associated with nosocomial infection (Jarvis, et 
al., 1991; Yamashita et al., 2000), particularly among patients with  poor glucose control 
(Pomposelli et al., 1998).  The analysis examined factors associated with early 
readmissions for patients having CABG or PCI, and also determined the effect of 
diabetes complications on readmissions.  The analysis also examined the association of 
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discharge disposition with readmission.  Three discharge statuses were examined: 
discharge to home; discharge to home with home health care service (HHC); and 
discharge to a transitional care facility.  In identifying predictors of readmissions for 
individuals with diabetes, this study will assess how comorbid diabetes complications at 
the time of an index coronary revascularization hospitalization affect the likelihood of 
readmission.  The findings will add to our understanding of important factors to consider 
when planning post-discharge care for individuals with diabetes who have 
revascularization procedures, and may help reduce readmissions in this high-risk group.  
Moreover, it will help to identify modifiable factors to target for interventions.  The 
literature supports the following two hypotheses. 
Hypotheses  
 
1. Comorbid diabetes complications identified during the index hospitalization will be 
associated with a higher risk of hospital readmission among patients with diabetes having 
coronary revascularization, either CABG or PCI. 
Research on readmissions for patients with congestive heart failure and for CABG 
patients has identified diabetes as a predictor of readmission.  This association is 
consistent for 30-day readmission and for longer readmission durations (Krumholz, et al., 
2000; Stewart, et al., 2000).  Although there is little research on factors explaining 
readmission risk for patients with diabetes, studies have suggested complications of 
diabetes are independently associated with readmissions in the general population of 
patients with diabetes, and particularly among surgical patients with renal complications 
(Jiang, Stryer, Friedman, & Andrews, 2003; Molina-Corona & Zonana-Nacach, 2010; 
Moss, et al., 1999).  Studies have also shown that patients with poor control of diabetes 
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and poor self-management behaviors are more likely to miss primary care appointments; 
lack of primary care post discharge may increase the need for emergent care that may 
result in a readmission (Booth & Hux, 2003).  
2. Readmissions will be lower for patients discharged to home than for those discharged 
to transitional care, or to home with home care service.  
One aim of using transitional care is to improve care transition for patients with 
complex needs who are vulnerable to poor care if discharged to home (Anderson, Tyler, 
Helms, Hanson, & Sparbel, 2005; Coleman, 2003).  Patients discharged to home often 
have informal support that can provide necessary post-discharge care.  Additional home 
health care service is provided for those who lack informal support or need additional 
formal support (Anderson, Petersen, Kistner, Soltero, & Willson, 2006; Parsons & 
Gifford, 2002).  Ranking these discharge disposition types helps to identify patients at 
risk for poor health outcomes such as readmissions, and to provide services appropriate 
for their needs.  Among these potential discharge dispositions, discharge to transitional 
care for cardiac-related hospitalizations has increased substantially due to the need to 
save costs associated with cardiac surgery, increased adoption of fast track protocols,
 
early extubation, and early discharge (Bueno et al., 2010; Lazar, et al., 2001; Rashid, 
Sattar, Dar, & Khan, 2008).  Patients having cardiac surgery, and particularly those with 
multiple comorbidities, are more likely to be discharged to transitional care (Anderson, et 
al., 2006).  While studies have suggested that readmission rates from transitional care are 
high (Bini et al., 2010; Nasraway, Button, Rand, Hudson-Jinks, & Gustafson, 2000), few 
studies have assessed whether discharge to these facilities is associated with readmissions 
for patients undergoing revascularization procedures.  
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Design and Methods 
 
Conceptual Framework 
 
 The framework used in this study is based on the Process, Structures and 
Outcomes of Care in Cardiac Surgery (PSOCS) model developed by Shroyer and 
colleagues (Shroyer et al., 1995).  The PSOCS extends the Donabedian model 
(Donabedian, 1966) by adding patient factors, which represent individual patient risks 
and interval events, representing events that occurred post discharge that may affect the 
outcome of care.  As shown in Figure 5.1, the structure, process of care, patient risk and 
interval events are related to patient outcomes.  Patient characteristics represent illness 
severity, comorbidities, demographic characteristics, and socioeconomic factors.  The 
structure refers to the hospital setting, resources, and structure that may influence hospital 
practices and care delivery, and consequently patient outcomes.  The process of care 
represents the procedures and the care that the patient received during hospitalization.  
Differences in care process can affect care quality and outcomes.  For example, the 
CABG procedure is more complex than PCI in operative time and length of hospital stay, 
which are predictors of readmission (Bohmer, et al., 2002; Lahey et al., 1998; Smith, et 
al., 2006).  The interval events refer to events that occurred after discharge and may be 
associated with short or long-term outcomes.  These events include factors such as health 
behaviors, care after discharge, use of primary care services, and experiences unrelated to 
the cardiac surgery. 
Data Source  
 
 This analysis uses discharge information from the State Inpatient Database (SID) 
files from the Healthcare Cost and Utilization Project (HCUP) program at the Agency for 
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Quality and Research (AHRQ).  The SID databases represent all inpatient discharges 
from participating states, standardized as part of the HCUP program (HCUP, 2011b).  For 
this study, the SID databases for Arizona, California, and Florida were used because 
these states have a large representation of older adults and minority and ethnic groups, 
and a large number of revascularization discharges.  In addition, these states have a high 
percentage of verifiable patient identifiers needed to link hospital visits and to assess 
readmissions (HCUP, 2011a).  Discharges from Arizona were 20% of the sample data; 
those from California were 43%; those from Florida were 45%.  Variables assessing 
potential differences among the states were included in the analysis.  The core data 
elements in the SID databases include de-identified inpatient discharge-level data with 
information about demographic characteristics, patient disposition, length of stay, payer 
information, comorbidities, procedures, and diagnoses.  Hospital characteristics were not 
assessed due to a lack of data on hospital characteristics.  
Study Population 
 
 The study sample consists of patients age 45 and older who had CABG or PCI at 
Arizona, California, or Florida community hospitals in 2007.  The sample was restricted 
to patients age 45 and older because increasing age is associated with having a CABG 
procedure and the risks for adverse outcomes after revascularization (Brooks et al., 2000; 
Magee, Coombs, Peterson, & Mack, 2003; Vavlukis, Georgievska-Ismail, Bosevski, & 
Borozanov, 2006).  About 95% of CABGs and PCIs were for patients age 45 and older  
in 2007 (HCUPnet., 2010).  Patients were included if their discharge record had one of 
the following International Classification of Diseases, Ninth Revision, Clinical 
Modification (ICD-9-CM) procedure codes: 36.10-36.19, 00.66, and 36.01, 36.02, 
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36.05-36.07, discharged alive and having any diagnosis codes indicating that they had 
diabetes, shown in Table 5.1.  Patients were considered to have a comorbid diabetes 
complication if they had diabetes and any of the following conditions: renal, ophthalmic, 
and neurological manifestations; peripheral circulatory disorders; uncontrolled diabetes; 
chronic kidney disease; or renal failure.  Of the 141,568 hospitalizations when a CABG 
or PCI procedure was performed, 42,396 discharges met the selection criteria.  Those 
discharged to other hospitals or with missing discharge disposition were excluded 
(n=618). 
Outcomes 
 
 The outcome of interest in this study was early (≤10 days) and late (11 to 30 days) 
readmission after discharge.  Readmission was defined as the first admission for any 
cause after a hospitalization with CABG or PCI.  The top 10 primary diagnoses on first 
readmission were also identified.  The number of days between the date of discharge and 
subsequent admission measured the time to readmission.  
Explanatory Variables of Key Interest 
 
 The key explanatory variables of interest were discharge disposition and 
comorbid diabetes complications on index admission.  For discharge disposition, the 
categories were: discharged to home without home health care service (referent); 
discharged to home with home health care service; and discharged to transitional care.   
Covariates 
 
 Other covariates included clinical characteristics, comorbidities, diagnoses and 
procedures identified or performed during the index admission, type of health insurance, 
medical history, and demographic factors.  Categories of patient disposition on discharge, 
109 
 
        
9
6
 
age, race/ethnicity, health insurance, and admission type were dummy coded, with the 
group having the most observations as the referent group.  In some cases, such as age, the 
referent group was the group with the lowest risk if there was evidence of relative risk 
from the literature.  The categories of health insurance were Medicare (referent), 
Medicaid, private, and self-pay.  Age was categorized as: 45-54 (referent), 55-64, 65-74, 
and 75 and older.  For race and ethnicity, the groups were African American (hereafter 
Black), non-Hispanic white (hereafter White) (referent), Hispanic, Asian or Pacific 
Islander, and Native American or other (mixed race) (Trivedi, Sequist, & Ayanian, 2006), 
as shown in Table 5.2.  Native Americans were included in the ―other‖ race group due to 
their small number in the analytic dataset.  Dummy variables representing the states were 
included in the analysis. The referent state was Florida because it had the most 
observations.   
Comorbidities 
  The Elixhauser comorbidity list used in this analysis, which includes 30 
comorbidities, has been validated for use with administrative data (Elixhauser, Steiner, 
Harris, & Coffey, 1998; Friedman, Jiang, Elixhauser, & Segal, 2006; Stukenborg, 
Wagner, & Connors, 2001; Yan, Birman-Deych, Radford, Nilasena, & Gage, 2005).  The 
algorithm differentiates between comorbidities and complications due to the care process 
by conservatively considering only secondary diagnoses unrelated to the 
diagnosis-related group (DRG) assigned to the discharge.  A secondary diagnosis related 
to the DRG was considered a contributor to illness severity rather than a comorbid 
condition.  For example, a patient with valve disorder with a cardiac DRG was not coded 
as having a valve disorder comorbidity, although it is likely that the valve disorder would 
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contribute to her or his illness severity.  For this study, separate variables for secondary 
diagnoses related to the DRG were created to indicate markers of illness severity.  Thus, 
in addition to the 30 Elixhauser comorbidities, variables for illness severity were created 
for secondary diagnoses of congestive heart failure, valve disorder, and pulmonary 
disorder.  Each comorbid condition was included in the analyses as a dichotomous 
variable, ―Yes/No.‖  In addition, the total number of comorbid conditions for each patient 
was included in the multivariate analyses, to adjust for potential associations between an 
increasing number of comorbidities and the outcomes.   
Statistical analysis 
 
Differences in characteristics for patients readmitted and those not readmitted 
were compared using the t-test for continuous variables and the chi-square statistic for 
categorical variables.  To evaluate whether diabetes complications and discharge 
disposition were associated with readmission, Kaplan-Meier analyses were conducted 
using the log-rank test, with censoring at 30 days.  Cox proportional hazards models 
assessed the association between characteristics of patients and their care during the 
index hospitalization, with particular focus on discharge disposition and comorbid 
diabetes complications, and the hazard of readmission.  The hazard function curve in 
Figure 5.2 shows multiple peaks, an indication of multiple changes in direction, and thus 
supports using the Cox hazard model (Allison, 2010).  Adherence to the proportional 
hazards assumption was verified using log-cumulative hazard plots, time-dependent 
covariates, and Schoenfeld residuals (Allison, 2010; Fisher & Lin, 1999).  Separate 
multivariate models were fit for readmissions that occurred within 10 days after 
discharge, categorized as early readmission, and 11 to 30 days after discharge, 
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categorized as late readmission.  The point used to stratify readmission was based on the 
point where the hazard function rate changed.  As shown in Appendix B, the log-
cumulative hazard plot for diabetes complications diverged at day 5, suggesting the 
relationship of diabetes complications and readmission may vary with time.  Thus, a 
time-dependent covariate was created to assess the effect of comorbid diabetes 
complications within 5 days of discharge.  This time-dependent variable was not 
significant and was not included in the final models. 
All models included adjustments for age, sex, race/ethnicity, health insurance, 
household income, and comorbidities.  Patients with unknown discharge disposition and 
those discharged to other acute care hospitals were excluded from the analyses.  The fit of 
the models was checked using log-likelihood statistics and covariates were manually 
eliminated from the models based on their p-values.  Hazard ratios (HRs) and their 95% 
Confidence Intervals (CIs) were estimated.  P-values <0.05 were considered to be 
statistically significant.  All analyses were conducted using SAS (Version 9.2 SAS 
institute) and JMP ® Software (Version 8 SAS institute). 
Results 
 
Sample Characteristics 
 
The crude survival rate for readmission within 30 days of discharge and the 
descriptive characteristics of the study population are shown in Figure 5.4 and presented 
in Table 5.3.  Figure 5.4 shows that by day 5 only 2% had been readmitted.  By day 10, 
the cumulative number of readmissions had doubled, with 4% of the patients having been 
readmitted.  Of the 41,778 patients included in the study, 13.5% were readmitted.  Table 
5.3 shows that men were 65.4% of the analytic sample; 11.9% of the sample had 
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comorbid diabetes complications.  Most were discharged to home without HHC (75.3%), 
followed by those discharged to home with HHC (16.7%); 8% were discharged to 
transitional care.  The most common primary diagnoses and procedures at first 
readmission are presented in Table 5.4.  Cardiac-related diagnoses accounted for five out 
of the ten top primary diagnoses, postoperative infection and complications of graft were 
among the top 10.  The most common procedure during readmissions was angioplasty, 
accounting for 14.1% of all readmission procedures.  
Bivariate Analyses 
 
Descriptive differences between patients readmitted and those who were not 
readmitted are presented in Table 5.5.  Compared to those who were not readmitted, 
those readmitted were more likely to be 75 years and older (32.1% vs. 24.4%, p<.0001), 
women (38.7% vs. 33.9%, p<.0001), Blacks (6.8% vs. 5.8%, p=.0016), Hispanics (16.5% 
vs. 15.4%, p=.0295) and to have public health insurance.  In addition, those readmitted 
were more likely to have been discharged to home with home health care service (18.6% 
vs. 16.4%, p<.0001) and to transitional care (17.6.7% vs. 6.5%, p<.0001).  Other factors 
that were different included clinical characteristics such as atrial fibrillation, acute 
myocardial infarction and comorbidities.  Most of these characteristics were more 
common among readmitted patients.    
Multivariate Analyses 
 
 Tables 5.6 and 5.7 present the hazard ratios (HRs) and their confidence intervals 
(CIs) for the hazard of readmission.  Table 5.6 presents the hazard ratios associated with 
early readmission.  Table 5.7 presents the hazard ratios associated with late readmission.  
Diabetes complications were associated with 24% greater risk of early readmission (HR 
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1.24, CI 1.08-1.42).  In Appendix B, Figure 5.5 shows the crude lognormal plot of 
diabetes complications during early readmissions.  In the first five days after discharge, 
the risk of readmission between those with diabetes complications and those without 
complications was similar.  However, this changed after day 5, as the risk increased for 
those with diabetes complications.  There was no significant difference in early 
readmission between those discharged to home with or without home health care (HR 
1.18, CI 0.98-1.42).  However, the relative risk of readmission for those discharged to 
transitional care was quite high (HR 4.16, CI 3.53-4.91).  Other factors associated with a 
higher likelihood of early readmission were comorbid cancer, arthritis, chronic 
obstructive pulmonary disease (COPD), drug abuse, and peripheral vascular disorders 
(PVD).  There were differences in readmission risks between the states.  Compared to 
Florida, those in Arizona (HR 1.36, CI 1.17-1.58) and California (HR 1.29, CI 1.08-1.55) 
had greater readmission risk.  Some factors were protective against early readmissions.  
These included having low median household income, private insurance or self-paid care. 
 For late readmissions (Table 5.7), having comorbid diabetes complications (HR 
1.27, CI 1.17-1.39) was a risk factor.  Race/ethnicity was associated with late 
readmissions, with Blacks (HR 1.17, CI 1.03 -1.34) and Hispanics (HR 1.10, CI 
1.00-1.20) at significantly higher risk than Whites.  Discharge both to home with home 
care service (HR 1.24, CI 1.12-1.36) and to transitional care facility (HR 1.88, CI 
1.69-2.10) were associated with a higher risk of late readmission compared to discharge 
to home without home care service.  Other risk factors for late readmission included 
depression (HR 1.16, CI 1.02-1.33), psychoses (HR 1.33, CI 1.08-1.64) and being female, 
atrial fibrillation, comorbid cancer, anemia, COPD, and PVD.  Older age was associated 
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with lower readmission.  Compared to those in the 45-54 age group, older patients were 
significantly less likely to have late readmission.  Other factors associated with lower 
readmission risk included having lower median household income, private health 
insurance, self-paying for care, and being uninsured.  The hazard ratios for late 
readmissions did not differ among the states.  
Discussion 
 
While it is still debated whether readmission is an effective measure of quality 
(Luthi, Burnand, McClellan, Pitts, & Flanders, 2004; Powell, Davies, & Thomson, 2003), 
evidence highlighting the cost implications and increased risks of morbidity and mortality 
associated with readmission is consistent (Ashton, Kuykendall, Johnson, Wray, & Wu, 
1995; Curtis, et al., 2009).  Outcomes of CABG and PCI have been widely studied due to 
the volume of these procedures performed annually in the U.S., risk for adverse 
outcomes, and the need to improve care quality and reduce associated costs (Eagle et al., 
2004; Smith, et al., 2006).  Although readmission can be influenced by the care process, 
patient risk factors are also important predictors of the likelihood of readmission (Curtis, 
et al., 2009; Hannan, et al., 2003; Sun, et al., 2008).  Understanding these risk factors can 
help enhance effective management of patient care, both inpatient and outpatient, to 
reduce readmissions.  Among CABG and PCI patients, diabetes has been suggested as a 
predictor of readmissions (Curtis, et al., 2009; Hannan, et al., 2003; Stewart, et al., 2000; 
Sun, et al., 2008).  Previous studies have focused on the general CABG and PCI 
population or the general population of patients with diabetes (Jiang, et al., 2005; Jiang, 
et al., 2003; Moss, et al., 1999).  Little research has evaluated characteristics associated 
with readmission risk after coronary revascularization for patients with diabetes.  This 
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study addressed that research gap.  Further, the analysis examined associations between 
discharge disposition and readmission for this patient population.  
 This research assessed two hypotheses.  The first hypothesis was that comorbid 
diabetes complications present during an index hospitalization for patients having 
coronary revascularization would be associated with higher risk of readmission.  The 
study results support this hypothesis.  Patients with comorbid diabetes complications had 
higher risks of both early and late readmission.  Although there is limited research on 
readmissions among patients with diabetes complications after CABG or PCI, the finding 
of the present study is consistent with previous research (Jiang, et al., 2003; Moss, et al., 
1999; Tomlin, Tilyard, Dovey, & Dawson, 2006), in which diabetes complications were 
associated with multiple hospitalizations (Jiang, et al., 2003) whereas uncontrolled 
glucose and nephropathy were associated with readmissions (Molina-Corona & Zonana-
Nacach, 2010; Moss, et al., 1999).  The current study further clarifies this association by 
quantifying this risk in patient with diabetes having CABG and PCI.  One suggestion in 
the results was that the risk associated with diabetes complications may vary over time, 
with perhaps no associated risk in the first few days after discharge.   
 During the 5 days after discharge, those with and without diabetes complications 
had similar readmission risks.  However, this risk increased after day 5.  During 
hospitalization, management of diabetes and tight control of blood glucose is often 
maintained (Braithwaite et al., 2008; Yalla & Reynolds, 2009).  The late effect of the 
tight control of blood glucose during hospitalization may explain this observation.  If the 
diabetes was not adequately managed after discharge, the risk for readmission could 
increase over time. 
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The second hypothesis was that readmission risk would be lower for patients 
discharged to home without home health care than for those discharged to transitional 
care or to home with home health care.  The results support this hypothesis.  Compared to 
those discharged to home without home health care, the risks of early and late 
readmission were higher for those discharged to transitional care, and late readmission 
was higher for those discharged to home with home health care.  This result is consistent 
with findings from previous research on 30-day readmission for CABG patients that 
assessed discharge disposition and found patients discharged to home with services, or to 
transitional care, had significantly more readmissions (Bohmer, et al., 2002).  The current 
study also highlighted potential variations in the effect of discharge with HHC on 
readmission over time.  For readmission occurring within 10 days after discharge, 
discharge with HHC service was not significantly different from discharge to home.  
However, this changed for readmissions that occurred after 10 days following discharge.  
This difference in the risk of readmission for patients discharged to home with HHC over 
time may be due to changes in formal and informal post-discharge support (McCall, 
Petersons, Moore, & Korb, 2003).  Further, increased readmissions among patients 
discharged with HHC service after 10 days may be due to termination of the HHC 
service, a factor that was not analyzed in this study.  
There was strong evidence for the effect of neurological dysfunction on 
readmission, with depression and psychoses associated with 16% and 33% higher risk of 
late readmissions.  Changes in environment and social isolation, especially for patients 
discharged to transitional care, may explain the association between neurological 
dysfunction and readmission (Anderson, et al., 2005).  In another area, previous research 
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has indicated varying readmission risks for men and women and for several race/ethnic 
minority groups (Jiang, et al., 2005; Steuer et al., 2002).  This was confirmed in the 
current study, with women, Blacks and Hispanics more likely to have late readmission.   
Most of the primary diagnoses from readmissions were cardiac-related; the most 
common primary procedure was angiography.  Preliminary analysis of patients who had 
angiography during the first readmission, in relation to having had PCI during the index 
hospitalization, suggests that repeat PCI may be high for these patients.  Future research 
should focus on assessing the link between PCI during the index hospitalization and 
repeat PCI during a readmission.  
A strength of this study was that it provided information about factors that may 
increase readmission risk for patients with diabetes.  The large study sample permitted 
sub-group analyses and evaluation of readmissions at different intervals.  Stratifying the 
study analyses into early and late, based on changes in the hazard function, provided 
additional knowledge about readmission for patients with comorbid diabetes 
complications immediately after discharge and later.  Having data on patients‘ discharge 
disposition also allowed assessing its association with readmission.  
Despite the study‘s strengths, there are some limitations.  Although the sample 
represented the universe of CABG and PCI performed in the states studied, the findings 
may not be generalizable to the U.S. population.  The analyses were limited to discharges 
in 2007, and thus could not consider readmissions that occurred after this period. 
Eliminating discharges that occurred in December 2007 would have corrected this 
limitation; however, the month of discharge was not available for many patients.  The 
data did not provide information about the level or quality of care received at home with 
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or without HHC services, or at transitional care facilities; this level and quality may 
affect readmission.  Further, the data lack information on hospital characteristics, and the 
analysis could not control for the potential effects of hospital factors.  Other unmeasured 
factors that may affect readmission include the discharge process, and use of adjuvant 
therapy on discharge such as aspirin and β-blockers.  Adjusting readmission risks with 
relevant covariates, such as insurance status and income, may mitigate the effect of some 
unmeasured factors.  
Implications for Policy and Practice 
 
This study highlighted readmission risks following revascularization associated 
with comorbid diabetes complications.  Patients with comorbid diabetes complications 
were more likely to be readmitted.  While this risk was not observed in the days 
immediately following discharge, it steadily increased after 5 days following discharge.  
As poor management of diabetes is an important factor in the incidence of acute diabetes 
complications such as hyperglycemia, hypoglycemia, and ketoacidosis, the lack of 
adequate diabetes management may explain the higher risk of readmission for these 
patients.  Further research is necessary to identify vulnerabilities that may affect these 
patients, and perhaps to extend the analysis to the level of diabetes management they 
received during inpatient and outpatient care. 
Similarly, readmission risk in the first days following discharge did not differ 
between those discharged to home with or without home health care services.  The 
lognormal plot actually suggested a fewer readmissions in patients discharged to home 
with home health care than those discharge to home during this period.  However, this 
risk of readmission increased over time among patients discharged with home health 
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care.  Further research should seek to explain this variation and assess the potential effect 
of termination of the HHC services as possibly explaining increased late readmissions for 
patients using HHC services after discharge.  This should be evaluated, however, with 
consideration for potential scheduled readmissions or higher readmission risk unrelated to 
quality of care during the index hospitalization, associated with higher illness acuity or 
lack of informal care that may trigger arrangements for HHC services.  As more patients 
who have coronary revascularization are discharged to transitional care facilities, further 
focus on these patients would be useful to explain their greater risk of rehospitalization. 
Although using transitional care to extend care may be beneficial for some 
patients, it may not be cost-effective and beneficial for patients with diabetes, as more of 
them who have transitional care return to the hospital shortly after discharge.  Providing 
extended diabetes management and follow-up care after discharge may help reduce 
readmission risk for these patients. 
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Table 5.1: Criteria Used to Define Outcomes and Explanatory Variables 
Diagnosis and Procedure ICD-9-CM Codes
a
 
Coronary artery bypass graft 3610, 3611, 3612, 3613, 3614, 3615, 3616, 3617, 
3618, 3619 
Percutaneous coronary 
intervention 
0066, 3601, 3602, 3605, 3606, 3607  
Diabetes  25000-25033, 64800-64804   
Diabetes complications 25040 - 25093, 5853, 5854, 5855, 5856, 5859, 586,  
CABG history V4581 
PCI history V4582 
a
ICD-9-CM=International Classification of Diseases, 9th Revision, Clinical 
Modification; CABG=Coronary artery bypass graft; PCI=Percutaneous coronary 
intervention. 
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Table 5.2: Definition of Variable and Coding
a
  
Variable Definition  
  
Gender   Men 
 Women 
  Race Non-Hispanic White  
 Black 
 Hispanic 
 Asian/Pacific Islander 
 Native American/others 
  
Primary payer Medicare 
 Medicaid 
 Private insurance 
 Self-pay 
 Other 
 
Median household 
income
b
 
$45,000 or more 
 $25,000-34,999 
 $35,000-44,999 
 $1-24,999 
  
Discharge disposition
 
Home without home health care services 
 Home with home health care services 
 Transitional care facility
c
  
  
Age 45-54 
 55-64 
 65-74 
 74 and over 
  
Comorbidities Conditions diagnosed as secondary to the primary 
diagnosis and  unrelated to the patient assigned 
diagnosis-related group 
 a
Source: Nationwide Inpatient Sample, 2007. 
b
The median household income of the patient's ZIP Code of residence. 
c
Included: Skilled nursing facility, Intermediate care facility and rehabilitation facility. 
 
 
  
122 
 
        
9
6
 
Table 5.3: Descriptive Characteristics of Patients with Diabetes Having 
Coronary Revascularization (N=41,778), 2007
a
 
Readmission n % 
No 36143 86.5 
Yes 5635 13.5 
Gender     
Men 27320 65.4 
Women 14458 34.6 
Age     
45-54 5508 13.2 
55-64 11905 28.5 
65-74 13778 33.0 
75 and older 10587 25.3 
Discharge disposition     
Home 31443 75.3 
Home with home health care (HHC) 6978 16.7 
Transitional care facility (TCF) 3357 8.0 
Comorbid diabetes complications     
No 36788 88.1 
Yes 4990 11.9 
Race/Ethnicity     
White 28219 67.6 
Black 2463 5.9 
Hispanic 6487 15.5 
Asian 2084 5.0 
Other 1423 3.4 
Missing 1102 2.6 
Had PCI  29689 71.1 
Had CABG 12487 29.9 
Data source: 2007 Arizona, California, and Florida State Inpatient Databases (SIDs); 
CABG=Coronary artery bypass graft; PCI= Percutaneous coronary intervention 
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Table 5.4: Most Common Primary Diagnoses and Procedures at 
First Readmission, 2007
a
 
Diagnosis % n 
Acute myocardial infarction 15.8 932 
Congestive heart failure  8.4 495 
Rehabilitation 4.9 289 
Chest pain 4.9 287 
Postoperative infection 3.9 233 
Endocardia infarction 2.9 174 
Atrial fibrillation 1.8 106 
Pneumonia 1.67 99 
Unspecified chest pain 1.54 91 
Complications of graft or implant 1.47 87 
Procedure   
PCTA
a 
14.1 835 
Cardiac Catheterization 4.4 259 
Pleural tap 3.2 189 
Transfusion of packed cell 3.0 180 
Surgical occlusion of vessels 2.5 145 
Hemodialysis 3.6 126 
Physical therapy 2.7 94 
Diagnostic ultrasound 2.4 82 
Diagnostic endoscopic 2.0 69 
Defibrillator implant 1.8 61 
Data source: 2007 Arizona, California, and Florida State Inpatient Databases 
(SIDs);
 a
PCTA: Percutaneous coronary transluminal angioplasty.  
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Table 5.5: Baseline Characteristics of Patients According to Readmission 
Status Within 30 days of Discharge (N=41,778), 2007
a
 
  Readmission Status   
Demographics Yes (%)  No (%) P-value 
Age       
45-54 12.0 13.4 0.0023 
55-64 24.4 29.1 <.0001 
65-74 32.1 33.1 0.1176 
75 and older 32.1 24.4 <.0001 
Median household income       
$1-24,999 17.5 18.7 0.0301 
$25,000-34,999 17.0 17.8 0.1216 
$35,000-44,999 11.9 12.8 0.0526 
$50,000 and over 6.6 6.9 0.3270 
Race/Ethnicity       
White 66.5 67.7 0.0803 
Black 6.8 5.8 0.0016 
Hispanic 16.5 15.4 0.0295 
Asian 4.9 5.0 0.6687 
Other 3.3 3.4 0.7561 
Women 38.7 33.9 <.0001 
Health insurance       
Medicare 65.0 56.7 <.0001 
Medicaid 7.5 6.5 0.0065 
Self-Pay 1.6 2.5 <.0001 
Private insurance 22.2 29.7 <.0001 
Clinical characteristics     
Had PCI 67.1 71.7 <.0001 
Had CABG 34.3 29.2 <.0001 
History of PCI 16.0 17.3 0.0148 
Atrial fibrillation 21.1 14.9 <.0001 
Acute myocardial infarction 4.7 3.9 0.0051 
Postoperative stroke 3.2 1.7 <.0001 
Discharge disposition     
Home  63.7 77.1 <.0001 
Home with home health care 18.6 16.4 <.0001 
Transitional care facility 17.6 6.5 <.0001 
Comorbidities       
Diabetes complication 17.6 11.1 <.0001 
Peripheral vascular disorders 16.7 12.9 <.0001 
125 
 
        
9
6
 
COPD 23.1 16.9 0.0005 
Arthritis 2.0 1.4 0.0008 
Neurological disorders 3.9 2.4 <.0001 
Anemia deficiency 22.1 15.1 <.0001 
Electrolyte disorder 14.9 10.9 <.0001 
Depression 6.0 4.4 <.0001 
Psychoses 2.2 1.2 <.0001 
Cancer 2.2 1.4 <.0001 
a
Data source: 2007 Arizona, California, and Florida State Inpatient Databases (SIDs); 
CABG=Coronary artery bypass graft; PCI=Percutaneous coronary intervention; 
COPD=chronic obstructive pulmonary disorder. 
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Table 5.6: The Adjusted Hazard Ratio for Readmission at ≤10 days After 
Discharge, 2007
a
 
Parameters Estimate HR
a
 LB
b
 UB
c
 P-value 
Diabetes Complications 0.212 1.24 1.08 1.42 0.0022 
Log of length of stay -0.254 0.78 0.72 0.83 <.0001 
Women 0.107 1.11 1.01 1.23 0.0307 
Home Healthcare 0.166 1.18 0.98 1.42 0.0746 
Transitional care facility 1.426 4.16 3.53 4.91 <.0001 
Arizona state 0.309 1.36 1.17 1.58 <.0001 
California state 0.256 1.29 1.08 1.55 0.0052 
55-64 -0.033 0.97 0.82 1.14 0.6882 
65-74 -0.213 0.81 0.67 0.97 0.0234 
75 and older 0.022 1.02 0.85 1.24 0.8221 
$1-24,999 -0.220 0.80 0.66 0.97 0.0265 
$25,000-34,999 -0.167 0.85 0.70 1.03 0.0942 
$35,000-44,999 -0.143 0.87 0.70 1.07 0.1806 
Cancer 0.416 1.52 1.11 2.07 0.0088 
Medicaid -0.111 0.9 0.72 1.11 0.3058 
Self -0.483 0.62 0.41 0.92 0.0191 
Private -0.156 0.86 0.74 0.99 0.0330 
Arthritis 0.391 1.48 1.09 2.01 0.0128 
CHF -1.133 0.32 0.16 0.65 0.0016 
COPD 0.223 1.25 1.11 1.41 0.0003 
Drug Abuse 0.696 2.01 1.30 3.08 0.0015 
Hypertension  0.145 1.16 1.03 1.30 0.0175 
Peripheral vascular disorders 0.174 1.19 1.05 1.35 0.0079 
a
Data source: 2007 Arizona, California, and Florida State Inpatient Databases (SIDs); 
CABG=Coronary artery bypass graft; PCI= Percutaneous coronary intervention; 
CHF=congestive heart failure; COPD=chronic obstructive pulmonary disorder; Reference 
categories: Men, discharge to home without home health care services, Florida, age group 45-55, 
$50,000+ median household income, and Medicare. 
a
HR: Hazard ratio. 
b
LB: Lower bound of 
95% confidence interval.  
c
UB: Upper bound of 95% confidence interval.   
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Table 5.7: The Adjusted Hazard Ratio of Readmission at  >10 days Post-discharge, 
2007
a
 
Parameters Estimate HR
a
 LB
b
 UB
c
 P-value 
Diabetes complications 0.241 1.27 1.17 1.39 <.0001 
Length of stay 0.319 1.38 1.31 1.45 <.0001 
Black 0.160 1.17 1.03 1.34 0.0152 
Hispanic 0.095 1.10 1.00 1.20 0.0390 
Asian -0.015 0.99 0.85 1.15 0.8474 
Other 0.076 1.08 0.90 1.29 0.4017 
Missing  -0.315 0.73 0.58 0.92 0.0080 
Atrial Fibrillation 0.163 1.18 1.08 1.28 <.0001 
Women 0.090 1.09 1.02 1.17 0.0088 
Home Healthcare 0.211 1.24 1.12 1.36 <.0001 
Transitional care facility 0.633 1.88 1.69 2.10 <.0001 
Arizona State 0.076 1.08 0.96 1.21 0.1961 
California State 0.092 1.10 0.96 1.25 0.1582 
55-64 -0.166 0.85 0.76 0.95 0.0046 
65-74 -0.202 0.82 0.72 0.93 0.0019 
75 and older -0.165 0.85 0.74 0.97 0.0161 
$1-24,999 -0.102 0.90 0.79 1.03 0.1410 
$25,000-34,999 -0.014 0.99 0.86 1.13 0.8440 
$35,000-44,999 -0.046 0.96 0.83 1.10 0.5378 
Cancer 0.271 1.31 1.05 1.63 0.0150 
Medicaid 0.008 1.01 0.88 1.15 0.9129 
Self -0.457 0.63 0.49 0.82 0.0006 
Private -0.297 0.74 0.67 0.82 <.0001 
Uninsured -0.214 0.81 0.67 0.97 0.0221 
Nutritional deficiency -0.422 0.66 0.50 0.86 0.0026 
 Anemia deficiency 0.112 1.12 1.03 1.21 0.0062
COPD 0.168 1.18 1.10 1.28 <.0001 
Depression 0.151 1.16 1.02 1.33 0.0276 
Peripheral vascular disorders 0.091 1.10 1.00 1.19 0.0387 
Psychoses 0.286 1.33 1.08 1.64 0.0070 
a
Data source: 2007 Arizona, California, and Florida State Inpatient Databases (SIDs); 
CABG=Coronary artery bypass graft; PCI= Percutaneous coronary intervention; 
CHF=congestive heart failure; COPD=chronic obstructive pulmonary disorder; 
Reference categories: Men, discharge to home without home health care services, Florida, age group 
45-55, $50,000+ median household income, and Medicare. aHR: Hazard ratio.  
b
LB: Lower bound 
of 95% confidence interval. 
c
UB: Upper bound of 95% confidence interval. 
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Figure 5.1: Graphical Representation of Conceptual Model: from Shroyer et al., 1995 
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Figure 5.2: Cumulative Hazard Function for 30-day Readmissions 
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Figure 5.3: The LogNormal Cumulative Plot for Diabetes Complications and 10-day 
Readmissions 
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Figure 5.4: Survival Plot and Table Showing the Percentage Readmitted by Specific Days 
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APPENDIX A: THE DESCRIPTION AND CODING FOR BED SIZE 
BED SIZE CATEGORIES 
Location and Teaching Status  
Hospital Bed Size  
Small Medium Large 
NORTHEAST REGION  
Rural 1-49 50-99 100+ 
Urban, nonteaching 1-124 125-199 200+ 
Urban, teaching 1-249 250-424 425+ 
MIDWEST REGION  
Rural 1-29 30-49 50+ 
Urban, nonteaching 1-74 75-174 175+ 
Urban, teaching 1-249 250-374 375+ 
SOUTHERN REGION  
Rural 1-39 40-74 75+ 
Urban, nonteaching 1-99 100-199 200+ 
Urban, teaching 1-249 250-449 450+ 
WESTERN REGION  
Rural 1-24 25-44 45+ 
Urban, nonteaching 1-99 100-174 175+ 
Urban, teaching 1-199 200-324 325+ 
Source: Nationwide Inpatient Sample Documentation 
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APPENDIX B: THE UNADJUSTED CUMULATIVE PLOT OF READMISSIONS BY 
DIABETES COMPLICATIONS 
 
 
